<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Tissue Eng</journal-id><journal-id journal-id-type="iso-abbrev">J Tissue Eng</journal-id><journal-id journal-id-type="publisher-id">TEJ</journal-id><journal-id journal-id-type="hwp">sptej</journal-id><journal-title-group><journal-title>Journal of Tissue Engineering</journal-title></journal-title-group><issn pub-type="epub">2041-7314</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage UK: London, England</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6472158</article-id><article-id pub-id-type="doi">10.1177/2041731419841748</article-id><article-id pub-id-type="publisher-id">10.1177_2041731419841748</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Chronic optical pacing conditioning of h-iPSC engineered cardiac
tissues</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dwenger</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff2-2041731419841748">2</xref></contrib><contrib contrib-type="author"><name><surname>Kowalski</surname><given-names>William J</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff3-2041731419841748">3</xref><xref ref-type="aff" rid="aff4-2041731419841748">4</xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Fei</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff3-2041731419841748">3</xref></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Fangping</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff3-2041731419841748">3</xref></contrib><contrib contrib-type="author"><name><surname>Tinney</surname><given-names>Joseph P</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff3-2041731419841748">3</xref></contrib><contrib contrib-type="author"><name><surname>Setozaki</surname><given-names>Shuji</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff5-2041731419841748">5</xref></contrib><contrib contrib-type="author"><name><surname>Nakane</surname><given-names>Takeichiro</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff6-2041731419841748">6</xref></contrib><contrib contrib-type="author"><name><surname>Masumoto</surname><given-names>Hidetoshi</given-names></name><xref ref-type="aff" rid="aff6-2041731419841748">6</xref><xref ref-type="aff" rid="aff7-2041731419841748">7</xref></contrib><contrib contrib-type="author"><name><surname>Campbell</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff8-2041731419841748">8</xref></contrib><contrib contrib-type="author"><name><surname>Guido</surname><given-names>William</given-names></name><xref ref-type="aff" rid="aff8-2041731419841748">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5476-6050</contrib-id><name><surname>Keller</surname><given-names>Bradley B</given-names></name><xref ref-type="aff" rid="aff1-2041731419841748">1</xref><xref ref-type="aff" rid="aff2-2041731419841748">2</xref><xref ref-type="aff" rid="aff3-2041731419841748">3</xref><xref ref-type="corresp" rid="corresp1-2041731419841748"/></contrib></contrib-group><aff id="aff1-2041731419841748"><label>1</label>Kosair Charities Pediatric Heart
Research Program, Cardiovascular Innovation Institute, University of Louisville,
Louisville, KY, USA</aff><aff id="aff2-2041731419841748"><label>2</label>Department of Pharmacology &#x00026;
Toxicology, School of Medicine, University of Louisville, Louisville, KY, USA</aff><aff id="aff3-2041731419841748"><label>3</label>Department of Pediatrics, School of
Medicine, University of Louisville, Louisville, KY, USA</aff><aff id="aff4-2041731419841748"><label>4</label>Laboratory of Stem Cell and
Neurovascular Biology, Cell and Developmental Biology Center, National Heart Lung
and Blood Institute, National Institutes of Health, Bethesda, MD, USA</aff><aff id="aff5-2041731419841748"><label>5</label>Department of Cardiovascular Surgery,
Okamura Memorial Hospital, Shimizu, Japan</aff><aff id="aff6-2041731419841748"><label>6</label>Department of Cell Growth and
Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto
University, Kyoto, Japan</aff><aff id="aff7-2041731419841748"><label>7</label>RIKEN Center for Biosystems Dynamics
Research (BDR), Wako, Japan</aff><aff id="aff8-2041731419841748"><label>8</label>Department of Anatomical Sciences and
Neurobiology, School of Medicine, University of Louisville, Louisville, KY,
USA</aff><author-notes><corresp id="corresp1-2041731419841748">Bradley B Keller, Kosair Charities Pediatric
Heart Research Program, Cardiovascular Innovation Institute, University of
Louisville, 302 E. Muhammad Ali Blvd., Room 407, Louisville, KY 40202, USA.
Email: <email>brad.keller@louisville.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><season>Jan-Dec</season><year>2019</year></pub-date><volume>10</volume><elocation-id>2041731419841748</elocation-id><history><date date-type="received"><day>23</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>13</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which
permits non-commercial use, reproduction and distribution of the work
without further permission provided the original work is attributed as
specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><p>The immaturity of human induced pluripotent stem cell derived engineered cardiac
tissues limits their ability to regenerate damaged myocardium and to serve as
robust <italic>in vitro</italic> models for human disease and drug toxicity
studies. Several chronic biomimetic conditioning protocols, including mechanical
stretch, perfusion, and/or electrical stimulation promote engineered cardiac
tissue maturation but have significant technical limitations. Non-contacting
chronic optical stimulation using heterologously expressed channelrhodopsin
light-gated ion channels, termed optogenetics, may be an advantageous
alternative to chronic invasive electrical stimulation for engineered cardiac
tissue conditioning. We designed proof-of-principle experiments to successfully
transfect human induced pluripotent stem cell derived engineered cardiac tissues
with a desensitization resistant, chimeric channelrhodopsin protein, and then
optically paced engineered cardiac tissues to accelerate maturation. We
transfected human induced pluripotent stem cell engineered cardiac tissues using
an adeno-associated virus packaged chimeric channelrhodopsin and then verified
optically paced by whole cell patch clamp. Engineered cardiac tissues were then
chronically optically paced above their intrinsic beat rates <italic>in
vitro</italic> from day 7 to 14. Chronically optically paced resulted in
improved engineered cardiac tissue electrophysiological properties and subtle
changes in the expression of some cardiac relevant genes, though active force
generation and histology were unchanged. These results validate the feasibility
of a novel chronically optically paced paradigm to explore non-invasive and
scalable optically paced&#x02013;induced engineered cardiac tissue maturation
strategies.</p></abstract><kwd-group><kwd>Channelrhodopsin</kwd><kwd>engineered cardiac tissues</kwd><kwd>optical pacing</kwd><kwd>optogenetics</kwd><kwd>stem cells</kwd></kwd-group><funding-group><award-group id="award1-2041731419841748"><funding-source id="funding1-2041731419841748"><institution-wrap><institution>Kosair Charities Pediatric Heart Research
Endowment</institution><institution-id/></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section1-2041731419841748"><title>Introduction</title><p>Because the human heart cannot regenerate following injury and undergoes progressive
cardiac muscle loss and dysfunction, there is a broad interest to develop cellular
strategies for cardiac repair and regeneration.<sup><xref rid="bibr1-2041731419841748" ref-type="bibr">1</xref>,<xref rid="bibr2-2041731419841748" ref-type="bibr">2</xref></sup> Injected or infused cell
therapies result in modest improvements in myocardial function; however, greater
than 90% of cells are lost within the first few days following transplantation.<sup><xref rid="bibr1-2041731419841748" ref-type="bibr">1</xref></sup> Tissue engineering strategies that combine cells with supportive biomaterials
before transplantation result in increased cell survival and both myocardial
structural and functional recovery.<sup><xref rid="bibr3-2041731419841748" ref-type="bibr">3</xref><xref rid="bibr4-2041731419841748" ref-type="bibr"/><xref rid="bibr5-2041731419841748" ref-type="bibr"/><xref rid="bibr6-2041731419841748" ref-type="bibr"/><xref rid="bibr7-2041731419841748" ref-type="bibr"/><xref rid="bibr8-2041731419841748" ref-type="bibr"/><xref rid="bibr9-2041731419841748" ref-type="bibr"/><xref rid="bibr10-2041731419841748" ref-type="bibr"/><xref rid="bibr11-2041731419841748" ref-type="bibr"/><xref rid="bibr12-2041731419841748" ref-type="bibr"/><xref rid="bibr13-2041731419841748" ref-type="bibr"/><xref rid="bibr14-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr15-2041731419841748" ref-type="bibr">15</xref></sup> Tissue engineering strategies
utilizing cardiac patches, injectable delivery matrices, microspheres for cell
encapsulation, and engineered cardiac tissues (ECTs) all face the challenge of
cardiomyocyte (CM) immaturity, particularly when myocardial cells are derived from
human-induced pluripotent stem cells (h-iPSCs).<sup><xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref><xref rid="bibr9-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr10-2041731419841748" ref-type="bibr">10</xref>,<xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref></sup> ECTs have been generated from
a wide range of vertebrate cell sources<sup><xref rid="bibr3-2041731419841748" ref-type="bibr">3</xref>,<xref rid="bibr4-2041731419841748" ref-type="bibr">4</xref>,<xref rid="bibr6-2041731419841748" ref-type="bibr">6</xref>,<xref rid="bibr7-2041731419841748" ref-type="bibr">7</xref>,<xref rid="bibr9-2041731419841748" ref-type="bibr">9</xref>,<xref rid="bibr10-2041731419841748" ref-type="bibr">10</xref>,<xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref><xref rid="bibr13-2041731419841748" ref-type="bibr"/><xref rid="bibr14-2041731419841748" ref-type="bibr"/><xref rid="bibr15-2041731419841748" ref-type="bibr"/><xref rid="bibr16-2041731419841748" ref-type="bibr"/><xref rid="bibr17-2041731419841748" ref-type="bibr"/><xref rid="bibr18-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr19-2041731419841748" ref-type="bibr">19</xref></sup> and a wide range of tissue
geometries.<sup><xref rid="bibr5-2041731419841748" ref-type="bibr">5</xref>,<xref rid="bibr6-2041731419841748" ref-type="bibr">6</xref>,<xref rid="bibr7-2041731419841748" ref-type="bibr">7</xref>,<xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref>,<xref rid="bibr11-2041731419841748" ref-type="bibr">11</xref>,<xref rid="bibr13-2041731419841748" ref-type="bibr">13</xref>,<xref rid="bibr15-2041731419841748" ref-type="bibr">15</xref></sup> ECT implantation results in
structural and functional recovery in both small<sup><xref rid="bibr7-2041731419841748" ref-type="bibr">7</xref>,<xref rid="bibr10-2041731419841748" ref-type="bibr">10</xref><xref rid="bibr11-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref>,<xref rid="bibr15-2041731419841748" ref-type="bibr">15</xref>,<xref rid="bibr18-2041731419841748" ref-type="bibr">18</xref>,<xref rid="bibr20-2041731419841748" ref-type="bibr">20</xref></sup> and large animal<sup><xref rid="bibr9-2041731419841748" ref-type="bibr">9</xref>,<xref rid="bibr13-2041731419841748" ref-type="bibr">13</xref></sup> preclinical models. However,
immune rejection remains a major barrier to ECT survival post-implantation,
resulting in major efforts to generate immune tolerant allogeneic or autologous
h-iPSC cell sources for tissue repair and regeneration.</p><p>ECTs possess a range of immature structural and functional characteristics, including
immature sarcomeric structure, undeveloped ion exchange and storage
architecture<sup><xref rid="bibr4-2041731419841748" ref-type="bibr">4</xref>,<xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref>,<xref rid="bibr14-2041731419841748" ref-type="bibr">14</xref>,<xref rid="bibr18-2041731419841748" ref-type="bibr">18</xref>,<xref rid="bibr21-2041731419841748" ref-type="bibr">21</xref></sup> and reduced
force generation and relaxation characteristics compared to mature, adult
myocardium.<sup><xref rid="bibr17-2041731419841748" ref-type="bibr">17</xref>,<xref rid="bibr22-2041731419841748" ref-type="bibr">22</xref><xref rid="bibr23-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr24-2041731419841748" ref-type="bibr">24</xref></sup> Bioreactors
can mimic some <italic>in vivo</italic> conditions, such as cyclic stretch and
mechanical stresses via continuous or pulsatile perfusion and fluid shear forces,
and these bioreactors promote differentiation of immature cardiac cells.<sup><xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref>,<xref rid="bibr25-2041731419841748" ref-type="bibr">25</xref></sup> ECT perfusion increases
nutrient transport, and mechanical stretch modulates cytoskeletal architecture and
integrin binding, receptor tyrosine kinase activation, and GTPase activity, all
leading to accelerated growth and differentiation.<sup><xref rid="bibr25-2041731419841748" ref-type="bibr">25</xref>,<xref rid="bibr26-2041731419841748" ref-type="bibr">26</xref></sup></p><p>Electrical stimulation (ES) has been used to stimulate CM maturation for more than 2
decades<sup><xref rid="bibr25-2041731419841748" ref-type="bibr">25</xref>,<xref rid="bibr27-2041731419841748" ref-type="bibr">27</xref><xref rid="bibr28-2041731419841748" ref-type="bibr"/><xref rid="bibr29-2041731419841748" ref-type="bibr"/><xref rid="bibr30-2041731419841748" ref-type="bibr"/><xref rid="bibr31-2041731419841748" ref-type="bibr"/><xref rid="bibr32-2041731419841748" ref-type="bibr"/><xref rid="bibr33-2041731419841748" ref-type="bibr"/><xref rid="bibr34-2041731419841748" ref-type="bibr"/><xref rid="bibr35-2041731419841748" ref-type="bibr"/><xref rid="bibr36-2041731419841748" ref-type="bibr"/><xref rid="bibr37-2041731419841748" ref-type="bibr"/><xref rid="bibr38-2041731419841748" ref-type="bibr"/><xref rid="bibr39-2041731419841748" ref-type="bibr"/><xref rid="bibr40-2041731419841748" ref-type="bibr"/><xref rid="bibr41-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr42-2041731419841748" ref-type="bibr">42</xref></sup> and may promote CM
differentiation by replicating endogenous electric fields present during embryonic
development that influence cellular behavior, proliferation, and
migration.<sup><xref rid="bibr28-2041731419841748" ref-type="bibr">28</xref>,<xref rid="bibr29-2041731419841748" ref-type="bibr">29</xref></sup> In general, these techniques produce ES to the entire ECT via
field stimulation and studies using ECTs derived from rat CM demonstrated increased
myocyte volume fraction, alignment, and connexin-43 expression<sup><xref rid="bibr31-2041731419841748" ref-type="bibr">31</xref></sup> as well as a positive force&#x02013;frequency relationship, representative of a more
mature contractile phenotype.<sup><xref rid="bibr21-2041731419841748" ref-type="bibr">21</xref></sup> ES effects were also observed in h-iPS-derived ECTs, including greater force
generation and myofiber alignment and enhanced electrophysiological
properties.<sup><xref rid="bibr30-2041731419841748" ref-type="bibr">30</xref>,<xref rid="bibr33-2041731419841748" ref-type="bibr">33</xref></sup> At the cellular and molecular scale, ES was shown to induce a
hypertrophic CM response, including increased myosin light chain expression and
enhanced atrial natriuretic factor secretion, which may depend on calcium influx and
the calcium-calmodulin pathway due to the inhibition of atrial natriuretic factor
(ANF) secretion by nifedipine,<sup><xref rid="bibr32-2041731419841748" ref-type="bibr">32</xref></sup> and the activation of c-Jun N-terminal kinase (JNK), which could activate
downstream gene pathways.<sup><xref rid="bibr43-2041731419841748" ref-type="bibr">43</xref></sup> Intracellularly, ES triggered mitochondrial proliferation and maturation,<sup><xref rid="bibr39-2041731419841748" ref-type="bibr">39</xref></sup> increasing the expression of nuclear respiratory factor 1 (NRF-1) and
activator protein 1 (AP-1) transcription factors,<sup><xref rid="bibr40-2041731419841748" ref-type="bibr">40</xref>,<xref rid="bibr41-2041731419841748" ref-type="bibr">41</xref></sup> which are frequently
upregulated in response to cellular stress, as well as upregulation of a
muscle-specific metabolic gene, Adss1, through the involvement of the
calcineurin/NFAT3 and GATA4 pathways.<sup><xref rid="bibr42-2041731419841748" ref-type="bibr">42</xref></sup> Hybrid approaches, such as the combination of ES with topographical cues,
have enhanced cell morphology and contractile maturation<sup><xref rid="bibr27-2041731419841748" ref-type="bibr">27</xref></sup> and the combination of ES and mechanical stretch increased cell alignment and
nonlinear anisotropic behavior.<sup><xref rid="bibr44-2041731419841748" ref-type="bibr">44</xref></sup> In non-CM studies, ES increased cardiac gene expression and triggered
elongation and alignment perpendicular to the electric field in mesenchymal stem cells,<sup><xref rid="bibr45-2041731419841748" ref-type="bibr">45</xref></sup> and increased sarcomere organization in C2C12 myoblasts.<sup><xref rid="bibr34-2041731419841748" ref-type="bibr">34</xref></sup> However, although these structural and functional effects of ES are well
described, our understanding of the precise mechanisms by which ES induces ECT
differentiation and maturation is limited and they remain largely undefined.
Furthermore, while ES can produce beneficial effects, this technique is invasive,
can generate toxic Faradaic reactions at higher voltages, and has limited
spatiotemporal resolution.<sup><xref rid="bibr33-2041731419841748" ref-type="bibr">33</xref>,<xref rid="bibr45-2041731419841748" ref-type="bibr">45</xref><xref rid="bibr46-2041731419841748" ref-type="bibr"/><xref rid="bibr47-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr48-2041731419841748" ref-type="bibr">48</xref></sup> Furthermore, a major
limitation of in vitro experimental systems that directly electrically stimulate
engineered tissues is the complexity and expense of the apparatus and the
requirement to directly instrument each tissue. In contrast, a non-contacting
optogenetic stimulation system can be scaled to much larger culture ECT arrays
because of the lack of direct electrical instrumentation of individual tissues and
the relatively low cost and reusable nature of LED arrays.</p><p>Optogenetic stimulation is an alternative and, perhaps, less invasive and more
scalable strategy to stimulate ECT maturation versus traditional ES.<sup><xref rid="bibr45-2041731419841748" ref-type="bibr">45</xref></sup> Optogenetics involves the heterologous expression and subsequent light
stimulation of light-sensitive ion channels, channelrhodopsins (ChR), initially
derived from <italic>Chlamydomonas reinhardtii</italic>, and subsequently derived
from other algal species, to produce action potentials.<sup><xref rid="bibr49-2041731419841748" ref-type="bibr">49</xref></sup> Following heterologous expression of ChR, blue light stimulation causes an
all-trans retinal chromophore in the channel to isomerize to 13-cis retinal,
triggering an action potential.<sup><xref rid="bibr49-2041731419841748" ref-type="bibr">49</xref></sup> Since the initial study which utilized channelrhodopsin-2 (ChR2), a range of
neuroscience and cardiac studies have used ChR2 to generate controlled action
potentials in single cells and tissues.<sup><xref rid="bibr49-2041731419841748" ref-type="bibr">49</xref><xref rid="bibr50-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr51-2041731419841748" ref-type="bibr">51</xref></sup> These light sensitive ion
channels include point mutation chimeric ChR1 and ChR2 variants such as ChIEF, which
have been developed to produce large photocurrents with reduced light desensitization.<sup><xref rid="bibr52-2041731419841748" ref-type="bibr">52</xref></sup> Advantages of optogenetic stimulation compared to ES include noninvasiveness,
cell-specificity, sarcolemmal level negative-feedback, scalability, and the
potential for lower toxicity <sup><xref rid="bibr33-2041731419841748" ref-type="bibr">33</xref>,<xref rid="bibr45-2041731419841748" ref-type="bibr">45</xref>,<xref rid="bibr48-2041731419841748" ref-type="bibr">48</xref></sup></p><p>Cardiac optogenetic applications are relatively novel but demonstrate the utility of
this approach. ChR2 was successfully expressed and stimulated in mouse embryonic
stem cell (ESC) derived CM.<sup><xref rid="bibr46-2041731419841748" ref-type="bibr">46</xref></sup> Expressing ChR2 in human embryonic kidney (HEK) cells and showed that HEK
light stimulation could produce electrical wave propagation through the co-cultured
HEK-ChR2&#x02009;+&#x02009;CM monolayers.<sup><xref rid="bibr51-2041731419841748" ref-type="bibr">51</xref></sup> ChR2 was successfully applied for acute stimulation in the context of C2C12
myotubes and rat ECTs.<sup><xref rid="bibr53-2041731419841748" ref-type="bibr">53</xref>,<xref rid="bibr54-2041731419841748" ref-type="bibr">54</xref></sup> Cardiac optogenetics has been demonstrated in human cells as
well, expressing functional ChR2 in h-ESC and h-iPSC derived CM.<sup><xref rid="bibr47-2041731419841748" ref-type="bibr">47</xref>,<xref rid="bibr49-2041731419841748" ref-type="bibr">49</xref></sup> However, to
date no study has successfully expressed a functional ChR protein in ECTs composed
of h-iPSC CM, or used this approach to chronically stimulate and mature CM.
Therefore, in the current study, we expressed the ChIEF protein in h-iPSC-CM derived
ECTs to investigate the effects of optogenetic stimulation for 7&#x02009;days on h-iPSC ECT
structural and functional maturation.</p></sec><sec sec-type="materials|methods" id="section2-2041731419841748"><title>Materials and methods</title><sec id="section3-2041731419841748"><title>Construction of optogenetic human-iPSC derived ECTs</title><p>We generated ECTs from h-iPSCs (4-factor (Oct3/4, Sox2, Klf4, and c-Myc) line
201B6) produced at the Center for iPS Cell Research and Application, Kyoto,
Japan, as previously described.<sup><xref rid="bibr10-2041731419841748" ref-type="bibr">10</xref></sup> The h-iPSC line was maintained on thin-coat Matrigel (growth factor
reduced, 1:60 dilution; BD Biosciences, San Jose, CA) in 1&#x02009;ng/mL human basic
fibroblast growth factor (hbFGF; WAKO, Osaka, Japan) augmented mouse embryonic
fibroblast conditioned medium (MEF-CM) generated in our laboratory. For
cardiovascular (CV) cell lineage induction, we (1) treated undifferentiated
h-iPSCs with Versene (0.48 mM ethylenediaminetetraacetic acid (EDTA) solution;
Life Technologies, Carlsbad, CA) treatment, (2) re-plated cells at
1000&#x02009;mm<sup>-2</sup> on Matrigel-coated plates in hbFGF-augmented MEF-CM for
2&#x02013;3&#x02009;days, (3) overlaid with Matrigel (1:60 dilution) for an additional day, then
replaced the MEF-CM with RPMI&#x02009;+&#x02009;B27 medium (RPMI1640; Life Technologies, 2 mM
L-glutamine; Life Technologies, 1X B27 supplement without insulin; Life
Technologies) supplemented with 100&#x02009;ng/mL Activin A (R&#x00026;D, Minneapolis, MN)
and 100&#x02009;ng/mL Wnt3a (R&#x00026;D) for 24 h (differentiation day 0; d0), and (4)
added 10&#x02009;ng/mL human bone morphogenetic protein 4 (BMP4; R&#x00026;D) and 10&#x02009;ng/mL
hbFGF at d1 for 2 or 4&#x02009;days with no medium change.<sup><xref rid="bibr55-2041731419841748" ref-type="bibr">55</xref></sup> For CM and endothelial cell (EC) differentiation, we refreshed the
RPMI&#x02009;+&#x02009;B27 culture medium at d5, supplemented with VEGF165 (Miltenyi, Bergisch
Gladbach, Germany), and refreshed culture medium every other day. To generate a
predominantly mural cell (MC) population, we replaced the culture medium at d3
with RPMI&#x02009;+&#x02009;10% fetal bovine serum (FBS) medium (RPMI1640, 2 mM
<sc>l</sc>-glutamine, 10% FBS), and refreshed media every other day. On d15,
cells were stained with a combination of one or more cell surface antigen
reagents including anti-VCAM1 conjugated with allophyco-cyanin (APC, BioLegend),
anti-PDGFR&#x003b2; conjugated with phycoerythrin (PE, BD, Franklin Lakes),
anti-VE-cadherin conjugated with fluorescein isothiocyanate (FITC, BD),
anti-cardiac isoform of Troponin T (cTnT, ThermoFisher) tagged with Alexa-488
(Invitrogen), and anti-TRA-1-60 conjugated with FITC (BD). Cells were also
stained with a LIVE/DEAD Aqua dead cell staining kit (Invitrogen). Stained cells
were analyzed for cell population percentages using a BD LSRII Flow Cytometer
and DIVA software (BD).</p><p>For each ECT, we combined three million cells from the CM&#x02009;+&#x02009;EC and MC protocols.
We cultured two ECT groups to day 14 (D14). One group was not transfected and
did not undergo any light simulation. In the second D14 group, ECTs were
transfected and we performed chronic optical pacing (C-OP) as described below
from D7 to D14. We cultured an additional group of non-transfected tissues to
D28. Therefore, we had three ECT groups: D14 control, D14&#x02009;C-OP, and D28. The
final average CM/EC/MC% concentration was 60%/13%/12% for D14 control tissues,
56%/11%/14% for D14&#x02009;C-OP tissues, and 69%/6%/12% for D28 tissues.</p><p>We suspended each cell mixture in culture medium (Modified Dulbecco&#x02019;s Essential
Medium, Invitrogen) containing 20% FBS (Invitrogen) as previously described.<sup><xref rid="bibr10-2041731419841748" ref-type="bibr">10</xref></sup> We added the suspended cells to a solution of soluble acidic rat-tail
collagen type-1 (pH&#x02009;=&#x02009;3 in HCl; Sigma), neutralized with alkali buffer (0.2M
NaHCO<sub>3</sub>, 0.2M HEPES, 0.1 M NaOH), and Matrigel. The total volume
of the cell/matrix solution was 200 &#x003bc;L, with a collagen concentration of
0.67&#x02009;mg/mL and Matrigel fraction of 15%. We transfected cells with an
adeno-associated virus (AAV)1/2-CAG-oChIEF-tdTomato vector (VectorBioLabs,
Malvern, PA) added directly to the cell/matrix mixture at a multiplicity of
infection (MOI) of 500 based on pilot dose-transfection efficiency experiments
that resulted in at least 20% transfection efficiency without cell death and
resulted in 100% OP capture. Other than the addition of the AAV1-ChIEF
construct, all other ECT fabrication processes were similar to our previously
published methods.<sup><xref rid="bibr10-2041731419841748" ref-type="bibr">10</xref>,<xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref></sup> For control tissues and day 28 ECTs, we omitted this viral
transfection step. We then generated linear ECTs using a Flexcell&#x000ae; FX-5000TT
system and a collagen type-1 coated silicone membrane 6-well plate
(TissueTrain&#x000ae;, Flexcell International, Hillsborough, FL). Using vacuum suction,
we deformed the silicone membrane at the bottom of each well into a 20&#x02009;mm length
x 2&#x02009;mm width trough. We added 200 &#x003bc;L of the cell/matrix mixture to each
vacuum-generated trough to form a cylindrical ECT, with the ends extending onto
nylon mesh anchors. After 120&#x02009;min, we released the vacuum suction and added
pre-culture medium to the tissue (PM; alpha minimum essential medium (&#x003b1;MEM; Life
Technologies) augmented with 10% FBS, 100 U/mL penicillin-streptomyocin (Life
Technologies), and 5 &#x000d7; 10<sup>-5</sup> M 2-mercaptoethanol (Sigma)). During ECT
culture, we changed medium every 48 h. We conducted ECT formation and culture in
an incubator maintained at 37&#x000b0;C and 5% CO<sub>2</sub>.</p></sec><sec id="section4-2041731419841748"><title>Chronic light stimulation</title><p>We performed C-OP of ECTs from D7 to D14 of <italic>in vitro</italic> culture
using a custom-built LED (470&#x02009;nm Rebel LED, model SP-01-04, Luxeon, Alberta,
Canada) array driven by BuckPuck DC LED drivers (LEDsupply, Randolph, VT) and a
programmable microcontroller (Arduino Uno, Italy) to generate broad field
optical stimulation of all cells within the ECT, similar to the approach of
broad electrical field stimulation. We mounted the LEDs on a high-alpha heat
sink (Luxeon) for thermal management. We controlled the pulse width and
frequency of the LEDs using an Arduino Uno microcontroller (Italy). We
programmed the Arduino with free Arduino IDE software. We used a 5 ms pulse
width. At the beginning of each C-OP culture day, we measured the optical
maximum capture rate (MCR) using video microscopy (MU1000, AmScope, Irvine, CA).
The C-OP rate for the next 24 h was then set at a rate 0.5&#x02009;Hz below the MCR. We
recorded intrinsic beat rate, optical MCR, and C-OP rate daily from D7 to D14.
For D14 control ECTs and D28 ECTs, we only recorded the daily intrinsic
rate.</p></sec><sec id="section5-2041731419841748"><title>Force testing</title><p>We measured ECT mechanical function using a custom-isolated muscle testing system
containing temperature-regulated perfusion bath and pacing electrodes (model
801&#x02009;C, Aurora Scientific, Aurora, Ontario, Canada).<sup><xref rid="bibr18-2041731419841748" ref-type="bibr">18</xref></sup> On the final culture day (D14 or D28), we excised and placed each linear
ECT from the TissueTrain&#x000ae; plate in the perfusion bath filled with
2,3-butanedione monoxime (BDM) to temporarily halt ECT shortening. Using 10-0
nylon suture, we attached one end of the ECT to a force transducer (model 403A,
Aurora Scientific) and the other end to a thin metal shaft connected to a
micromanipulator for length adjustment. We washed out the BDM and filled the
perfusion chamber with warmed Tyrode&#x02019;s solution, pre-bubbled with 95/5%
O<sub>2</sub>/CO<sub>2</sub> gas. After a 20-min equilibration period,
including one Tyrode&#x02019;s change at the 10-min mark, we determined individual ECT
maximum length (<italic>L<sub>max</sub></italic>) by manually stretching the ECT
until we observed no further increase in active force. Each ECT was held at
<italic>L<sub>max</sub></italic> for all measurements. After a 5-min
equilibration period, we refreshed the Tyrode&#x02019;s solution and recorded force at
the intrinsic beat rate for 30&#x02009;s using a 2 kHz sampling rate. We then performed
electric field pacing of the ECT, starting at the intrinsic beat rate (rounded
to the nearest 0.5&#x02009;Hz) and then increasing in 0.5&#x02009;Hz increments while recording
for 10&#x02009;s at each pacing rate. We determined electrical MCR at the onset of 2:1
block. For a subset of D14&#x02009;C-OP ECTs (<italic>n</italic>&#x02009;=&#x02009;6), we optically
paced with a 470&#x02009;nm LED placed below the perfusion bath. We optically paced at
the intrinsic rate and then increased the OP rate in 0.5&#x02009;Hz increments until the
optical MCR. For each OP rate, we recorded force for 30&#x02009;s, including intrinsic
beating for 10&#x02009;s. Increasing pacing rate was associated with reduced active
force and increased passive force.</p><p>We measured ECT diameter at <italic>L<sub>max</sub></italic> from a digital image
recorded during testing (MU1000, AmScope, Irvine, CA), performed three
measurements per ECT, then used the mean diameter to calculate ECT
cross-sectional area assuming a circular geometry. For each electric field
pacing frequency, we calculated mean active stress
(<italic>&#x003c3;<sub>A</sub></italic>), relaxation time to 50% diastolic stress
(RT50), stress-frequency relationship, beat-to-beat hysteresis
(<italic>&#x003c3;<sub>bb</sub></italic>), and systolic potential energy. We
used Fourier analysis of the force trace to determine the MCR. We calculated
stress (<italic>&#x003c3;</italic>) as force divided by cross-sectional area. After
applying a low-pass Gaussian filter to smooth the data, we identified local
minima (<italic>&#x003c3;<sub>min</sub></italic>) and maxima
(<italic>&#x003c3;<sub>max</sub></italic>) stress values and calculated
<italic>&#x003c3;<sub>A</sub></italic> as the difference between each
<italic>&#x003c3;<sub>max</sub></italic> and its preceding
<italic>&#x003c3;<sub>min</sub></italic>. We calculated the mean
<italic>&#x003c3;<sub>A</sub></italic> at each captured frequency to determine
stress&#x02013;frequency relationship. We additionally calculated RT50 at 3.0&#x02009;Hz pacing.
To obtain <italic>&#x003c3;<sub>bb</sub></italic>, we calculated
<italic>&#x003c3;<sub>A</sub></italic> for each contraction cycle and then for each
pair of successive cycles, we calculated the magnitude of the difference in
<italic>&#x003c3;<sub>A</sub></italic> divided by the overall mean
<italic>&#x003c3;<sub>A</sub></italic>. We defined this value as
<italic>&#x003c3;<sub>bb</sub></italic> and calculated the mean
<italic>&#x003c3;<sub>bb</sub></italic> over all cycles. Systolic energy is
related to the stress-time integral, similar to pressure-volume area.<sup><xref rid="bibr23-2041731419841748" ref-type="bibr">23</xref></sup> We calculated the systolic stress-time integral for each
<italic>&#x003c3;<sub>min</sub></italic>-to-<italic>&#x003c3;<sub>min</sub></italic>
cycle, normalized to both time and <italic>&#x003c3;<sub>max</sub></italic>. Since our
ECT functional tests were performed at <italic>L<sub>max</sub></italic>,
contractions were isometric and we therefore only measured potential energy. We
calculated the mean normalized systolic stress-time integral and defined this
value as the mean systolic potential energy (SPE). All analyses were performed
with automated software developed in MATLAB&#x000ae; (Mathworks, Natick, MA).</p></sec><sec id="section6-2041731419841748"><title>Patch clamp</title><p>A limited number of proof of principle patch clamp recordings were performed as
previously described.<sup><xref rid="bibr56-2041731419841748" ref-type="bibr">56</xref></sup> In brief, we placed an ECT in a perfusion chamber filled with BDM treated
Tyrode&#x02019;s solution. Pulled borosilicate glass capillaries were filled with the
following solution: 117 mM K-gluconate, 13.0 mM KCl, 1 mM MgCl<sub>2</sub>, 0.07
mM CaCl<sub>2</sub>, 0.1 mM ethylene glycol-bis(&#x003b2;-aminoethyl
ether)-<italic>N,N,N&#x02032;,N&#x02032;</italic>-tetraacetic acid (EGTA), 10 mM HEPES, 2 mM
Na-ATP, and 0.4 mM Na-GTP. We randomly patched the filled borosilicate capillary
onto ChIEF-expressing single cells within the ECT. ChIEF-expressing cells were
identified with differential contrast imaging system fitted with a Chroma49005
filter for tdTomato expression. A blue light emitting diode (Prizmatix UHP 460,
Prizmatix, Southfield, MI) reflected into an objective was used to excite the
patched cell. A Multiclamp 700B amplifier was used for whole cell recordings. We
analyzed patch clamp data using pClamp 10&#x000ae; software (Molecular Devices,
Sunnyvale, CA).</p></sec><sec id="section7-2041731419841748"><title>Histological assessment</title><p>We collected ECTs at D14 or D28 after force testing, fixed them with 4%
paraformaldehyde (PFA) at room temperature for 30&#x02009;min, and stored in 1X PBS at
4&#x000b0;C until processing.</p></sec><sec id="section8-2041731419841748"><title>Whole mount tissue immunofluorescence staining</title><p>We washed fixed ECTs in 1% Triton X-100/PBS for 1&#x02009;h and then blocked with 1%
Triton X-100/PBS&#x02009;+&#x02009;10% FBS for 1&#x02009;h. To identify CM in ECTs, we applied a primary
antibody to cardiac troponin T (cTnT, Ms-295, ThermoFisher Scientific) 1:400 in
1% Triton X-100/PBS&#x02009;+&#x02009;10% FBS&#x02009;+&#x02009;0.2% sodium azide overnight at 4&#x000b0;C followed by a
wash with 1% Triton X-100/PBS&#x02009;+&#x02009;10%FBS for 1&#x02009;h and 1% Triton X-100/PBS for three
wash cycles of 10&#x02009;min each. We then incubated with Alexa Flour 488 donkey
anti-mouse IgG secondary antibody (Molecular Probes, Oregon, USA) in 1% Triton
X-100/PBS&#x02009;+&#x02009;10%FBS&#x02009;+&#x02009;0.2% sodium azide&#x02009;+&#x02009;5% donkey serum overnight at 4&#x000b0;C. We
stained nuclei with 4&#x02032;,6-diamidino-2-phenylindole (DAPI) (R37606, molecular
probes, Oregon, USA) for 30&#x02009;min at room temperature. After immunofluorescence
(IF) staining, we equilibrated ECT samples with 100% glycerol overnight followed
by 75% glycerol for 2 h. We cleared ECTs in 53% benzyl alcohol, 45% glycerol,
and 2% 1,4-diazabicyclo[2.2.2]octane (DABCO)<sup><xref rid="bibr57-2041731419841748" ref-type="bibr">57</xref></sup> for 2 h and then changed to fresh clearing solution overnight at the
dark. Processed samples were stored in clearing solution at 4&#x000b0;C for further
imaging.</p></sec><sec id="section9-2041731419841748"><title>IF staining for paraffin sections</title><p>We processed ECTs for paraffin blocks and cut into 5 &#x000b5;m sections for IF staining.
After blocking with 0.1 M glycine&#x02009;+&#x02009;0.5% Triton X-100/PBS, we applied a primary
antibody to cTnT (Ms-295, ThermoFisher Scientific) 1:400 in 1% bovine serum
albumin (BSA) to identify CM and Living Colors DsRed Polyclonal Antibody (Cat#
632495, Clontech, Takara Bio USA, Inc.) 1:300 in 1% BSA to identify
ChIEF-tdTomato expressing cells overnight at 4&#x000b0;C. We then incubated slides with
Alexa Flour 488 donkey anti-mouse IgG and Alexa Flour 594 donkey anti-rabbit IgG
secondary antibodies (Molecular Probes, Oregon, USA) in 5% donkey serum for 1.5
h at room temperature. We mounted slides with ProLong&#x000ae; Gold Antifade Reagent
with DAPI (Molecular Probes, Oregon, USA).</p></sec><sec id="section10-2041731419841748"><title>Image acquisition and analyses</title><p>We performed confocal imaging of whole-mount and paraffin sectioned ECTs using a
Nikon ECLIPSE Ti Confocal System (Nikon, Tokyo, Japan) attached to a Nikon Ti-E
inverted microscope platform and Nikon NIS Elements AR software (Nikon). Images
were saved as 12-bit raw files for further processing. For whole-mount ECTs, we
placed samples in a 10&#x02009;mm glass bottom dish filled with clearing solution and
acquired a 3D z-stack using a 10X 0.3 NA objective at 1024 x 1024 pixel density
and 3&#x02009;&#x003bc;m z-step. We acquired z-stack images to a depth just past the ECT
midpoint, typically 150 slices (679&#x02009;&#x003bc;m). Since our linear ECTs were symmetric,
we did not require the whole thickness for analysis. Images of paraffin sections
were obtained with a 40X 1.30 NA objective at 1024 x 1024 pixel density. We
acquired images of the ECT midsection and used a tiled image to capture the
entire ECT width.</p><p>We measured CM alignment from cTnT-stained whole-mount 3D images based on our
previous method.<sup><xref rid="bibr58-2041731419841748" ref-type="bibr">58</xref></sup> Alignment concentration <italic>&#x003ba;</italic> describes the concentration of
local orientation vectors around the mean direction. Higher values of
<italic>&#x003ba;</italic> indicate greater alignment. We quantified the CM and
transfected cell populations from cTnT- and tdTomato-stained 40X images of
paraffin sections. We segmented the DAPI, cTnT, and tdTomato channels separately
using the Chan-Vese level set method.<sup><xref rid="bibr59-2041731419841748" ref-type="bibr">59</xref></sup> Prior to segmentation, we preprocessed the DAPI channel with a rolling
ball background subtraction<sup><xref rid="bibr60-2041731419841748" ref-type="bibr">60</xref></sup> and the cTnT and tdTomato channels with contrast-limited adaptive
histogram equalization.<sup><xref rid="bibr61-2041731419841748" ref-type="bibr">61</xref></sup> From the DAPI image, we separated individual nuclei using a watershed and
vertex graph algorithm.<sup><xref rid="bibr62-2041731419841748" ref-type="bibr">62</xref></sup> For each individual nucleus, we compared the overlap between the nucleus
boundary and the segmented cTnT and tdTomato images to determine CM and
transfected identity. We recorded the percent cTnT-positive, tdTomato-positive
and double-positive nuclei. We performed all image analyses with Matlab&#x000ae;
(Mathworks, Natick, MA).</p></sec><sec id="section11-2041731419841748"><title>Real-time quantitative polymerase chain reaction</title><p>We performed qPCR as described in our previous work.<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref></sup> We homogenized fresh ECT samples in Trizol reagent (Life Technologies,
Cat. No: 15596026), using an Omnitip Tissue homogenizer (USA Scientific, Ocala,
USA; Cat. No. 6615-7273) and isolated total RNAs with the RNeasy Mini Kit
(Qiagen, Valencia, USA; Cat. No. 74104) according to the manufacturer&#x02019;s
instructions. We measured RNA quality and quantity using the NanoDrop ND-2000
(ThermoFisher Scientific). Both 260/280 and 260/230 ratios of RNA samples were
approximately 2.00. We performed reverse transcription with the SuperScript VILO
cDNA synthesis system (Invitrogen, Cat. No.11754-050). To conduct qPCR, we
applied TaqMan Gene Expression Assays (ThermoFisher Scientific) with a
StepOnePlus Real-time PCR system (Applied Biosystems) and used 18&#x02009;S rRNA as
endogenous control. All qPCR experiments were performed with 2&#x02013;3 biological
replicates and technical triplicates for each group.</p></sec><sec id="section12-2041731419841748"><title>Statistical analyses</title><p>We statistically compared D14 control (<italic>n</italic>&#x02009;=&#x02009;13) and C-OP tissues
(<italic>n</italic>&#x02009;=&#x02009;15). We also statistically compared C-OP ECTs
(<italic>n</italic>&#x02009;=&#x02009;15) to a prolonged culture D28 tissues
(<italic>n</italic>&#x02009;=&#x02009;2). To establish a comparison between two groups, we
used unpaired Student&#x02019;s <italic>t</italic>-test at a significance level of
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec sec-type="results" id="section13-2041731419841748"><title>Results</title><sec id="section14-2041731419841748"><title>ChIEF transfection of h-iPSC-derived CMs within ECTs successfully results in
acute and C-OP</title><p>Following initial pilot experiments using several AAV constructs and transfection
doses, we transfected differentiated h-iPSC derived cardiac cells with an
AAV1/2-CAG-ChIEF-tdTomato virus at an MOI of 500 by adding virus directly to the
cell/matrix mixture at the time of ECT formation. All transfected cells
expressed the tdTomato reporter, and this MOI did not change the % of CM within
h-iPSC ECTs and the mean CM fraction was similar in D14 control
(<italic>n</italic>&#x02009;=&#x02009;9) and C-OP (<italic>n</italic>&#x02009;=&#x02009;10). D14C-OP ECTs
began to spontaneously beat after 3&#x02009;days of culture, similar to control ECTs
(<xref ref-type="fig" rid="fig1-2041731419841748">Figure 1</xref>).</p><fig id="fig1-2041731419841748" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>ECT formation and chronic optical pacing (C-OP) protocol: (a) ECTs were
generated from a multi-component mixture of cardiomyocytes, endothelial
cells, and mural cells, differentiated from h-iPSCs. Cells were mixed
with culture medium, collagen I, and Matrigel.
AAV1/2-CAG-oChIEF-tdTomato virus was then added to the gel mixture at
500 MOI. The gel mixture was poured into FlexCell&#x000ae; TissueTrain&#x000ae; wells
deformed into a cylindrical mold by vacuum suction and anchored by nylon
mesh tabs. The TissueTrain&#x000ae; plate was placed on top of an
Arduino-controlled LED platform for chronic optical pacing. ECTs were
cultured at 37&#x02009;C, 5% CO<sub>2</sub>. (b) At culture day 7, C-OP was
initiated. C-OP ECTs were stimulated with a pulsed 470&#x02009;nm LED. A
representative C-OP protocol is shown. At each culture day, we measured
the maximum capture rate (MCR) and set the C-OP rate at 0.5&#x02009;Hz below
MCR.</p></caption><graphic xlink:href="10.1177_2041731419841748-fig1"/></fig></sec><sec id="section15-2041731419841748"><title>Force&#x02013;length and force&#x02013;frequency testing of C-OP h-iPSC ECTs confirm
functional maturation</title><p>OP during <italic>in vitro</italic> force testing confirmed OP capture (<xref ref-type="fig" rid="fig2-2041731419841748">Figure 2</xref>). Electric field
pacing was used for all quantitative force-length and force-frequency data
collection in order to compare our results to other published studies using ES.
We noted rate-dependent changes in both passive and active stress typical of
immature myocardium (<xref ref-type="fig" rid="fig2-2041731419841748">Figure
2</xref>). We noted a negative force&#x02013;frequency relationship (reduced active
force at higher pacing frequencies) typical for immature ECTs (<xref ref-type="fig" rid="fig2-2041731419841748">Figure 2</xref>).</p><fig id="fig2-2041731419841748" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Representative force tracings at increasing electrical pacing rates
display decreasing active force and increasing beat-to-beat hysteresis:
Active force decreased and passive force increased during each stepwise
increase in pacing rate: (a) 3 to 3.5 to 3 Hz. (b) 4 to 4.5 to 4 Hz. (c)
5 to 5.5 to 5 Hz. While difficult to see at the 3&#x02009;Hz (180 beats per
minute), at higher pacing rates there is an incremental increase in the
amplitude variation between sequential beats, termed beat-to-beat
hysteresis. Greater beat-to-beat hysteresis at increasing pacing rates
suggests greater phase lag in calcium cycling at higher beat rates,
consistent with immature myocardium. s: seconds; mN: millinewtons.</p></caption><graphic xlink:href="10.1177_2041731419841748-fig2"/></fig><p>As described in the Materials and Methods section, we developed an automated
Matlab analysis module to quantify ECT performance (<xref ref-type="fig" rid="fig3-2041731419841748">Figure 3</xref>).</p><fig id="fig3-2041731419841748" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Analysis of ECT performance: For this representative example, a C-OP ECT
is analyzed at an acute electrical pacing rate of 4.5&#x02009;Hz. Mean
<italic>&#x003c3;<sub>A</sub></italic> was 0.29 mN/mm<sup>2</sup>,
<italic>&#x003c3;<sub>bb</sub></italic> was 0.17, RT50 was 63&#x02009;ms, and
normalized systolic energy was 0.53. (a) Representative stress versus
time data. Force data were divided by ECT cross-sectional area to
calculate stress. A cycle is defined as contraction followed by
relaxation. The minimum stress before the onset of contraction is
<italic>&#x003c3;<sub>min</sub></italic> and the peak stress is
<italic>&#x003c3;<sub>max</sub></italic>. Active stress,
<italic>&#x003c3;<sub>A</sub></italic>, is the difference between
<italic>&#x003c3;<sub>max</sub></italic> and
<italic>&#x003c3;<sub>min</sub></italic>. Beat-to-beat hysteresis,
<italic>&#x003c3;<sub>bb</sub></italic>, is the magnitude of the
difference between the <italic>&#x003c3;<sub>A</sub></italic> of an
even-numbered cycle and the <italic>&#x003c3;<sub>A</sub></italic> of the
preceding odd-numbered cycle, divided by the overall mean
<italic>&#x003c3;<sub>A</sub></italic>. (b) Fast Fourier transform (FFT)
analysis of the stress versus time signal. An acute electrical pacing
frequency was considered captured if it matched the peak frequency of
the FFT power spectrum. (c) RT50 calculated for cycle 1 in (a). RT50 is
the time for stress to relax by 50% of <italic>&#x003c3;<sub>A</sub></italic>
from <italic>&#x003c3;<sub>max</sub></italic>. (d) Normalized systolic energy
calculated for cycle 1 in (a). Stress and cycle time were both
normalized to a maximum value of 1. The area of the shaded region under
the stress-time curve is related to systolic energy during
contraction.</p></caption><graphic xlink:href="10.1177_2041731419841748-fig3"/></fig><p>We confirmed acute OP triggered CM depolarization and action potential generation
within D14C-OP ECTs using pulsed blue light stimulation and patch clamp
recording (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(a)</xref>)
through visual inspection as well as brief video recordings. Acute OP captured
all beats when paced above the intrinsic beat rate until reaching the MCR. Both
the D14C-OP and D28 ECTs achieved higher electric field paced MCRs versus D14
control ECTs (5.37&#x02009;&#x000b1;&#x02009;0.69 vs 6.50&#x02009;&#x000b1;&#x02009;0.71 vs 4.35&#x02009;&#x000b1;&#x02009;0.59&#x02009;Hz,
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(b)</xref> and (<xref ref-type="fig" rid="fig4-2041731419841748">c</xref>)), indicating improved ECT maturation after C-OP. However, the MCR
for D14C-OP ECTs was less than that of D28 ECTs (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05,
<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(c)</xref>).
Consistent with this trend in CM maturation, RT50 measured at 3.0&#x02009;Hz decreased
in D14C-OP ECTs compared to controls (88.00&#x02009;&#x000b1;&#x02009;9.60 vs 104.23&#x02009;&#x000b1;&#x02009;6.66&#x02009;ms,
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(d)</xref>) and further decreased by D28
(65.60&#x02009;&#x000b1;&#x02009;2.12, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 vs D14&#x02009;C-OP, <xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(d)</xref>). We additionally observed
that D14C-OP ECTs displayed a less negative stress&#x02013;frequency relationship than
control ECTs while D28 ECTs displayed the least negative stress&#x02013;frequency
relationship (<xref ref-type="fig" rid="fig4-2041731419841748">Figure
4(e)</xref>), consistent with ECT functional maturation. Consistent with
pacing induced maturation in calcium cycling and mechanical restitution, we
noted reduced <italic>&#x003c3;<sub>bb</sub></italic> at higher frequencies in D14C-OP
ECTs compared to D14 control ECTs (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(f)</xref>). Of note,
<italic>&#x003c3;<sub>bb</sub></italic> was negligible by D28 (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(f)</xref>). ECT
<italic>&#x003c3;<sub>A</sub></italic> was similar between D14 control and
D14C-OP ECTs (0.72&#x02009;&#x000b1;&#x02009;0.39 vs 0.52&#x02009;&#x000b1;&#x02009;0.27 mN/mm<sup>2</sup>,
<italic>p</italic>&#x02009;=&#x02009;0.14, <xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(g)</xref>), and D14 control and D14C-OP ECTs had similar CM
percentages (50&#x02009;&#x000b1;&#x02009;13 vs 48&#x02009;&#x000b1;&#x02009;13). <italic>&#x003c3;<sub>A</sub></italic> trended lower
for D28 ECTs (0.17&#x02009;&#x000b1;&#x02009;0.11, <italic>p</italic>&#x02009;=&#x02009;0.08 vs D14 control, <xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(g)</xref>) consistent
with reduced CM survival following prolonged ECT <italic>in vitro</italic>
culture. Systolic energy, a normalized contractile efficiency index calculated
at 3&#x02009;Hz, significantly decreased in D14C-OP ECTs compared to D14 control ECTs
(0.47&#x02009;&#x000b1;&#x02009;0.03 vs 0.54&#x02009;&#x000b1;&#x02009;0.02&#x02009;J/m<sup>3</sup>-s, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001,
<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(h)</xref>). As
expected, systolic energy was lower in the more functionally mature D28 ECTs
compared to D14C-OP ECTs (0.41&#x02009;&#x000b1;&#x02009;0.01&#x02009;J/m<sup>3</sup>-s,
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 vs D14&#x02009;C-OP, <xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(h)</xref>).</p><fig id="fig4-2041731419841748" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Impact of chronic optical pacing (C-OP) on functional maturation of
h-iPSC ECTs: (a) Representative patch clamp recording from a D14h-iPSC
CM after ECT ChIEF transfection. Blue ticks indicate 470&#x02009;nm light
pulses. (b) Representative stress trace during acute optical pacing of a
C-OP ECT. After 3&#x02009;s of spontaneous beating, we began acute pacing with a
470&#x02009;nm 3.5&#x02009;Hz pulsed LED. (c) Mean intrinsic beat rate and maximal
capture rate (MCR) for D14 control (<italic>n</italic>&#x02009;=&#x02009;13), D14&#x02009;C-OP
(<italic>n</italic>&#x02009;=&#x02009;15) and D28 (<italic>n</italic>&#x02009;=&#x02009;2) ECTs.
Intrinsic beat rate increased after C-OP and MCR increased after C-OP
and prolonged culture to D28. (d) Mean RT50 AT 3&#x02009;Hz acute electrical
pacing decreased after C-OP and after prolonged culture to D28. (e)
Stress-frequency curves showed a less negative relationship after C-OP
or prolonged culture to D28. (f) Pacing rate dependent beat-to-beat
hysteresis decreased after C-OP and was absent in D28 ECTs. (g) Mean
active stress was similar in D14 control and C-OP ECTs and trended lower
in D28 ECTs (<italic>p</italic>&#x02009;=&#x02009;0.08 vs D14 control). (h) Mean
normalized systolic energy at 3&#x02009;Hz acute electrical pacing decreased
after C-OP and further decreased by D28. Error bars show standard
deviations. See (c) for color legend. Results in (c&#x02013;h) obtained with 5&#x02009;V
acute electrical field pacing.</p><p>*<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 vs D14
control, &#x02020;<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 vs D28.</p></caption><graphic xlink:href="10.1177_2041731419841748-fig4"/></fig></sec><sec id="section16-2041731419841748"><title>C-OP does not accelerate structural maturation</title><p>We quantified the impact of C-OP on structural maturation through IF of fixed
D14C-OP and D14 control ECTs. Whole h-iPSC ECTs (<xref ref-type="fig" rid="fig5-2041731419841748">Figure 5(a)</xref>) were placed into 2D paraffin
blocks for serial section processing (<xref ref-type="fig" rid="fig5-2041731419841748">Figure 5(b)</xref> and (<xref ref-type="fig" rid="fig5-2041731419841748">c</xref>)) or stained as whole mounts for 3D
confocal imaging (<xref ref-type="fig" rid="fig5-2041731419841748">Figure
5(d)</xref>, (<xref ref-type="fig" rid="fig5-2041731419841748">g</xref>) and
(<xref ref-type="fig" rid="fig5-2041731419841748">i</xref>)). ChIEF proteins
predominantly co-located with cTnT-positive cells consistent with preferential
CM transfection (<xref ref-type="fig" rid="fig5-2041731419841748">Figure
5(c)</xref>). D14 control and C-OP ECTs displayed similar CM fractions
(50&#x02009;&#x000b1;&#x02009;13% vs 48&#x02009;&#x000b1;&#x02009;13%, <xref ref-type="fig" rid="fig5-2041731419841748">Figure
5(e)</xref>). In D14C-OP ECTs, 20&#x02009;&#x000b1;&#x02009;6% of CM were transfected and 67&#x02009;&#x000b1;&#x02009;14%
of all transfected cells were CM. In contrast to the functional maturation noted
after 7&#x02009;days of C-OP, CM alignment was similar between D14 control and C-OP ECTs
(&#x003ba;&#x02009;=&#x02009;3.76&#x02009;&#x000b1;&#x02009;1.11 vs 3.42&#x02009;&#x000b1;&#x02009;1.33, <xref ref-type="fig" rid="fig5-2041731419841748">Figure 5(f)</xref>). The 3D distribution and
alignment of local CM orientations were also similar between D14 control (<xref ref-type="fig" rid="fig5-2041731419841748">Figure 5(g)</xref> and (<xref ref-type="fig" rid="fig5-2041731419841748">h</xref>)) and D14C-OP (<xref ref-type="fig" rid="fig5-2041731419841748">Figure 5(i)</xref> and (<xref ref-type="fig" rid="fig5-2041731419841748">j</xref>)) ECTs, consistent with
the similar <italic>&#x003c3;<sub>A</sub></italic> noted above (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(g)</xref>).</p><fig id="fig5-2041731419841748" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Impact of chronic optical pacing (C-OP) on structural maturation of
h-iPSC ECTs: (a) Representative, linear and cylindrical h-iPSC ECT
constrained at the long axis ends by mesh nylon anchors. (b&#x02013;c)
Representative central paraffin sections of a (b) D14 control ECT
showing 54% CM and (c) D14&#x02009;C-OP ECT showing 52% CM and 13%
ChIEF-transfected cells. Nuclei were stained with DAPI (blue), CM with
cTnT (green) and ChIEF-transfected cells with tdTomato (red). CM were
predominantly located at the outer surface and the majority of
transfected cells were CM. Inset in (c) shows higher magnification of
double-positive cTnT and tdTomato cells. (d) Whole mount confocal image
of a control D14 ECT. (e) Mean CM fraction and (f) mean alignment
concentration (<italic>&#x003ba;</italic>) were similar in D14 control
(<italic>n</italic>&#x02009;=&#x02009;9) and C-OP (<italic>n</italic>&#x02009;=&#x02009;10) h-iPSC
ECTs. Error bars show standard deviations. (g&#x02013;j) Representative local CM
orientations within D14 (g) control and (i) C-OP h-iPSC ECTs.
Color-coded lines indicate local CM orientation magnitudes in the
circumferential (green), radial (red), and axial (blue) directions. For
clarity, only a subset of the orientations is shown. Insets are 3X
magnification of regions enclosed by the yellow dashed lines. (h and j)
Spherical histograms of local CM orientations. CM in both control and
C-OP aligned parallel to the ECT long axis. The volume of each ray
represents the relative count in each direction and the mean CM
orientation is shown by the thick red line. <italic>&#x003ba;</italic> for the
control sample (h) was 3.89 while the C-OP sample (j) was 3.46. Scale
bars: 5&#x02009;mm (a), 250&#x02009;&#x003bc;m (b, c, d, g, i), and 100&#x02009;&#x003bc;m (c inset).
Orientation axes also serve as scale bars in (d, g, i).</p></caption><graphic xlink:href="10.1177_2041731419841748-fig5"/></fig></sec><sec id="section17-2041731419841748"><title>C-OP upregulates a potassium channel that contributes to cardiac
repolarization</title><p>We performed RNA analysis on biologic triplicates of D14 control, D14C-OP ECTs,
and D28 ECTs (<xref ref-type="fig" rid="fig6-2041731419841748">Figures 6</xref>
and <xref ref-type="fig" rid="fig7-2041731419841748">7</xref>). cTnT (<xref ref-type="fig" rid="fig6-2041731419841748">Figure 6(a)</xref>), SERCA2A
(<xref ref-type="fig" rid="fig6-2041731419841748">Figure 6(a)</xref>), and
KCNJ2 (<xref ref-type="fig" rid="fig6-2041731419841748">Figure 6(b)</xref>)
mRNAs, common markers for maturity, were not upregulated in D14C-OP tissues. The
ratio of MLC2v and MLC2a, an indicator of ventricular phenotype development, was
also similar. KCND3, a transcript encoding the Kv4.3 ion channel responsible for
the transient outward potassium current (I<sub>to</sub>)<sup><xref rid="bibr63-2041731419841748" ref-type="bibr">63</xref></sup> was significantly upregulated twofold in D14C-OP ECTs (<xref ref-type="fig" rid="fig6-2041731419841748">Figure 6(b)</xref>). A single
biological replicate of RT-qPCR was completed on RNA isolated from D28 ECTs
(<xref ref-type="fig" rid="fig7-2041731419841748">Figure 7</xref>). RNA
analysis of D28 ECTs had been previously completed for D28 large format h-iPSC
ECTs and showed similar results.<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref></sup> Common structural and electrophysiological genes were upregulated in the
D28 ECTs from this study: RYR2, SERCA2A, Cacna1D, SCN4A, KCND3 (<xref ref-type="fig" rid="fig7-2041731419841748">Figure 7</xref>). The types of
genes increased reflecting the enhanced electrophysiological properties of the
extended ECT culture. SERCA2A and RYR2 could underlie the improved function of
D28 ECTs.</p><fig id="fig6-2041731419841748" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Quantitative PCR of genes encoding contractile proteins, Ca<sup>2+</sup>
cycling mechanisms, and ion channels in D14 control and C-OP ECTs: (a)
expression of genes related to CM contraction (cardiac troponin T (cTnT)
ventricular myosin light chain 2 (MLC2v) atrial MLC2 (MLC2a) and
MLC2v/MLC2a ratio) and genes related to Ca<sup>2+</sup> transients
(ryanodine receptor 2 (RYR2) ATPase sarcoplasmic/endoplasmic reticulum
Ca<sup>2+</sup> transporting 2 (SERCA2A), phospholamban (PLN),
calsequestrin 2 (CASQ2) aspartate beta-hydroxylase (ASPH), and
sodium/calcium exchanger 1 (SLC8A1) C-OP did not produce significant
differences in expression of contractile- or Ca<sup>2+</sup>
transient-related genes. (b) Expression of genes encoding sarcolemmal
voltage-gated L-type Ca<sup>2+</sup> channels (Cacna1&#x02009;C, Cacna1D),
T-type Ca<sup>2+</sup> (Cacna1G), Na<sup>+</sup> (SCN4A, SCN5A), and
K<sup>+</sup> (KCNH2 (rapidly activating delayed rectifying), KCNJ2,
KCNJ12 (inward rectifying), KCND3 (transient outward)) and connexin
(GJA1). C-OP resulted in a significant increase in the expression of the
transient outward K<sup>+</sup> channel KCND3. Expression of all other
ion channels and connexin were unchanged after C-OP.
*<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05. For each gene, 2&#x02013;4 biological experiments
were conducted and qPCR was performed in triplicate for each biological
sample. Error bars show standard deviations.</p></caption><graphic xlink:href="10.1177_2041731419841748-fig6"/></fig><fig id="fig7-2041731419841748" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Quantitative PCR for a single biological experiment comparing D14
control, D14 C-OP, and D28 ECTs: (a) Expression of genes related to CM
contraction (cardiac troponin T (cTnT) ventricular myosin light chain 2
(MLC2v) atrial MLC2 (MLC2a) and MLC2v/MLC2a ratio) and genes related to
Ca<sup>2+</sup> transients (ryanodine receptor 2 (RYR2) ATPase
sarcoplasmic/endoplasmic reticulum Ca<sup>2+</sup> transporting 2
(SERCA2A) phospholamban (PLN), and calsequestrin 2 (CASQ2) Expression
was similar for all genes in D14 control and C-OP, following the full
qPCR study in <xref ref-type="fig" rid="fig3-2041731419841748">Figure
3</xref>. The MLC2v/MLC2a was increased in the D28 sample,
suggesting a more ventricular phenotype, while increased RYR2 and
SERCA2A and decreased PLN suggest more mature Ca<sup>2+</sup> handling.
(b) Expression of genes encoding sarcolemmal voltage-gated L-type
Ca<sup>2+</sup> channels (Cacna1&#x02009;C, Cacna1D), T-type Ca<sup>2+</sup>
(Cacna1G), Na<sup>+</sup> (SCN4A, SCN5A), and K<sup>+</sup> (KCNJ2
(inward rectifying), KCND3 (transient outward)) and connexin (GJA1). The
expression of transient outward K<sup>+</sup> channel KCND3 increased in
both the C-OP and D28 samples, suggesting a role for this channel in
electrophysiological maturation during C-OP. L-type Ca<sup>2+</sup> and
Na<sup>+</sup> were also increased in the D28 sample, but did not
show a similar increase in C-OP ECTs. These data come from a single
experiment and are not sufficient for statistical analysis.</p></caption><graphic xlink:href="10.1177_2041731419841748-fig7"/></fig></sec></sec><sec sec-type="discussion" id="section18-2041731419841748"><title>Discussion</title><p>Our findings show that CMs within h-iPSC ECTs effectively express ChIEF after AAV
transfection, and 2D paraffin sections confirmed co-localization of cTnT and ChIEF
in D14C-OP ECTs (<xref ref-type="fig" rid="fig5-2041731419841748">Figure 5C</xref>),
consistent with a previously published study that showed efficient expression of ChR
in h-iPSC-CMs.<sup><xref rid="bibr47-2041731419841748" ref-type="bibr">47</xref></sup> Co-localization may explain how optical stimulation directly perturbed the CM
cell membrane to produce action potentials and trigger myocyte contraction.</p><p>Acute optical stimulation during patch clamp and force testing demonstrated action
potential generation and contraction in response to light excitation (<xref ref-type="fig" rid="fig1-2041731419841748">Figure 1(a)</xref> and (<xref ref-type="fig" rid="fig1-2041731419841748">b</xref>)). Efficient CM stimulation
requires action potential generation; therefore, we validated action potential
generation in response to acute optical stimulation by patch clamp.<sup><xref rid="bibr24-2041731419841748" ref-type="bibr">24</xref></sup> In native tissue, action potential generation couples to calcium-induced
calcium release from the SR (excitation-contraction coupling).<sup><xref rid="bibr24-2041731419841748" ref-type="bibr">24</xref></sup> We confirmed excitation-contraction coupling by optical stimulation using
force testing (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(b)</xref>).
Optical stimulation during force testing could pace tissues to a maximum rate of
5&#x02009;Hz, demonstrating comparable excitation&#x02013;contraction coupling to ES. It is worth
noting that ES resulted in higher MCRs than acute optical stimulation, possibly due
to greater percentage capture of CM during ES.</p><p>We performed C-OP of ECTs for 7 days to test the hypothesis that C-OP can induce ECT
functional maturation. We chose ChIEF because this channel does not desensitize with
chronic light stimulation, and we chose an AAV1 vector because of its safety and
efficient transfection of h-iPSC-CMs.<sup><xref rid="bibr52-2041731419841748" ref-type="bibr">52</xref>,<xref rid="bibr64-2041731419841748" ref-type="bibr">64</xref>,<xref rid="bibr65-2041731419841748" ref-type="bibr">65</xref></sup> These three properties
exhibited utility as demonstrated by the significant results of C-OP (<xref ref-type="fig" rid="fig1-2041731419841748">Figures 1</xref> and <xref ref-type="fig" rid="fig5-2041731419841748">5(b)</xref>). Similar CM percentages
between D14 control and D14C-OP ECTs supported low AAV toxicity (<xref ref-type="fig" rid="fig5-2041731419841748">Figure 5(e)</xref>). We added the
AAV1-ChIEF at the time of ECT formulation rather than after ECT gel compaction to
assure a uniform distribution of the vector within the ECT. Successful C-OP also
demonstrated the usefulness of our custom-built LED system.</p><p>C-OP increased both ECT MCR and intrinsic beat rate (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(c)</xref>). However, D28 control ECTs still
captured at a higher rate than D14C-OP ECTs consistent with our previous study
showing induction of maturation by extended in vitro culture (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(c)</xref>).<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref></sup> MCR is an integrated measure of CM maturation and higher capture rates
correlate with increased connexin-43 expression and potassium channel
expression.<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref>,<xref rid="bibr33-2041731419841748" ref-type="bibr">33</xref></sup> The 1&#x02009;Hz increase in MCR after C-OP is comparable to previous
chronic ES studies.<sup><xref rid="bibr25-2041731419841748" ref-type="bibr">25</xref>,<xref rid="bibr33-2041731419841748" ref-type="bibr">33</xref>,<xref rid="bibr38-2041731419841748" ref-type="bibr">38</xref></sup> C-OP did not mature ECTs by decreasing spontaneous beating,<sup><xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref></sup> and instead we found an increase in intrinsic beat rate (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(c)</xref>). This result differs from an ES
study of h-iPSC derived cardiac spheroids that showed a decrease in spontaneous
beating rate possibly due to a reduction of HCN4 mRNA, a gene encoding a pacemaking channel.<sup><xref rid="bibr36-2041731419841748" ref-type="bibr">36</xref></sup> However, our findings are consistent with a study of mouse-derived cardiac
embryoid bodies in which spontaneous beating increased in response to ES.<sup><xref rid="bibr3-2041731419841748" ref-type="bibr">3</xref></sup> Possibly, C-OP induced an upregulation of HCN4 channels, unlike normal
electrophysiological maturation.</p><p>C-OP also decreased <italic>&#x003c3;<sub>bb</sub></italic>, RT50, and systolic energy
consumption (<xref ref-type="fig" rid="fig1-2041731419841748">Figure 1(d)</xref>,
(<xref ref-type="fig" rid="fig1-2041731419841748">f</xref>) and (<xref ref-type="fig" rid="fig1-2041731419841748">h</xref>)). Similar to MCR, these
parameters decreased further in D28 ECTs compared to D14C-OP ECTs. Improvement in
hysteresis and RT50 also correlate with increased connexin-43 expression and
upregulation of potassium channel expression.<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref></sup> Mathematical modeling demonstrates hysteresis occurs due to out-of-phase
action potentials and calcium cycling.<sup><xref rid="bibr66-2041731419841748" ref-type="bibr">66</xref></sup> Thus, we propose that the decreased hysteresis indicates maturation of
excitation&#x02013;contraction coupling. ES studies have shown an improvement in relaxation
time similar to our result following C-OP.<sup><xref rid="bibr21-2041731419841748" ref-type="bibr">21</xref></sup> D14C-OP and D28 ECTs used less systolic energy during contraction at 3&#x02009;Hz
pacing as indicated by decreased stress-time integral values. The stress-time
integral relates to energy consumption during contraction.<sup><xref rid="bibr22-2041731419841748" ref-type="bibr">22</xref></sup> Increased expression of mitochondrial genes and mitochondria number could
underlie this result, as observed in ES of neonatal rat CM.<sup><xref rid="bibr39-2041731419841748" ref-type="bibr">39</xref></sup></p><p>C-OP ECTs maintained <italic>&#x003c3;<sub>A</sub></italic>, as a function of increasing
pacing frequency, better than control constructs, but not to the same degree as D28,
particularly at the higher pacing rates of 4.5 and 5&#x02009;Hz (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(e)</xref>). The underlying mechanism for
improved maintenance of <italic>&#x003c3;<sub>A</sub></italic> production correlates with
increased expression and development calcium handling structures.<sup><xref rid="bibr21-2041731419841748" ref-type="bibr">21</xref></sup> Calcium handling maturation could increase stress preservation due to quicker
calcium release and reuptake.<sup><xref rid="bibr21-2041731419841748" ref-type="bibr">21</xref></sup> Even though C-OP improved stress preservation, it did not reach the threshold
of generating a positive force&#x02013;frequency relationship as observed in a previous ES
study and extended culture study.<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref>,<xref rid="bibr21-2041731419841748" ref-type="bibr">21</xref></sup></p><p>We observed a decreasing trend in absolute <italic>&#x003c3;<sub>A</sub></italic> from D14
control to D14C-OP ECTs to D28 ECTs, although this result was not significant (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(g)</xref>). Possibly, C-OP,
ChR expression, or AAV transfection decreased <italic>&#x003c3;<sub>A</sub></italic> through
cell toxicity that was not evident by histology (<xref ref-type="fig" rid="fig5-2041731419841748">Figure 5(e)</xref>). C-OP may generate hydrodynamic
shear, a morphology-altering force.<sup><xref rid="bibr25-2041731419841748" ref-type="bibr">25</xref></sup> The neutral response of <italic>&#x003c3;<sub>A</sub></italic> to C-OP contrasts with
chronic ES, which has been noted to increase active force by 1.5 times.<sup><xref rid="bibr30-2041731419841748" ref-type="bibr">30</xref></sup> However, the difference in the results of C-OP could be due to our pacing at
around 3&#x02009;Hz rather than pacing at a lower rate of 2&#x02009;Hz/1.5&#x02009;Hz.<sup><xref rid="bibr30-2041731419841748" ref-type="bibr">30</xref></sup> Lower pacing rates may be more conducive to <italic>&#x003c3;<sub>A</sub></italic>
improvements.</p><p>Alignment analysis of 3D whole mount images showed C-OP did not alter cell
orientation (<xref ref-type="fig" rid="fig4-2041731419841748">Figure 4(h)</xref> and
(<xref ref-type="fig" rid="fig4-2041731419841748">j</xref>)). This result
suggests C-OP may not affect pathways related to cell migration. ES, unlike C-OP,
correlates with cellular alignment in some cases.<sup><xref rid="bibr31-2041731419841748" ref-type="bibr">31</xref>,<xref rid="bibr35-2041731419841748" ref-type="bibr">35</xref></sup> However, the direct causal
effect of ES on cell alignment remains unclear. Other studies have demonstrated
topographical cues influence alignment more than ES or that a combination of
mechanical stretch and ES is required to improve alignment.<sup><xref rid="bibr27-2041731419841748" ref-type="bibr">27</xref>,<xref rid="bibr44-2041731419841748" ref-type="bibr">44</xref></sup> Additional
research is needed to understand the mechanistic relationship between stimulating
ECT contraction and CM alignment.</p><p>RT-qPCR analysis identified KCND3, the gene encoding the Kv4.3 channel responsible
for the I<sub>to</sub> current, as a potential candidate for the
electrophysiological maturation induced by C-OP.<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref>,<xref rid="bibr63-2041731419841748" ref-type="bibr">63</xref></sup> This channel provides a
partial mechanism for electrophysiological maturation as the KCND3 mRNA was the only
gene significantly upregulated in D14C-OP ECTs (<xref ref-type="fig" rid="fig6-2041731419841748">Figure 6(b)</xref>). KCND3 also increased in the one
biological replicate of D28 ECTs, as well as our previous study of D28 large format ECTs,<sup><xref rid="bibr12-2041731419841748" ref-type="bibr">12</xref></sup> relating the KCND3 increase to maturation (<xref ref-type="fig" rid="fig7-2041731419841748">Figure 7(b)</xref>). Furthermore, increased
expression of Kv4.3 could improve hysteresis and MCR as the channel decreases
repolarization time; overexpression of Kv4.3 in isolated guinea pig myocytes
decreased membrane potential during the plateau phase and shortened action potential duration.<sup><xref rid="bibr67-2041731419841748" ref-type="bibr">67</xref></sup> Surprisingly, RNA analysis did not reveal significant upregulation of calcium
handling structures to explain <italic>&#x003c3;<sub>A</sub></italic> preservation, unlike
D28 ECTs (<xref ref-type="fig" rid="fig5-2041731419841748">Figures 5(a)</xref> and
<xref ref-type="fig" rid="fig7-2041731419841748">7(a)</xref>). Our RNA result
was consistent with a previous ES study that showed no upregulation of SERCA2A.<sup><xref rid="bibr30-2041731419841748" ref-type="bibr">30</xref></sup> Additional experiments including western blot analysis would validate
differences at the protein level as observed previously with ES.<sup><xref rid="bibr21-2041731419841748" ref-type="bibr">21</xref></sup></p><p>As stated previously, ECTs possess an immature phenotype which confounds translation
into CV regeneration therapies or drug testing platform technologies.<sup><xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref>,<xref rid="bibr68-2041731419841748" ref-type="bibr">68</xref></sup> Bioreactors induce
differentiation and maturation by replicating <italic>in vivo</italic> signals:
mechanical stretch, perfusion, and ES.<sup><xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref>,<xref rid="bibr25-2041731419841748" ref-type="bibr">25</xref></sup> However, no ECT differentiates
into a fully mature construct.<sup><xref rid="bibr8-2041731419841748" ref-type="bibr">8</xref></sup> Also, ES can be invasive and produces toxic Faradaic reactions.<sup><xref rid="bibr33-2041731419841748" ref-type="bibr">33</xref>,<xref rid="bibr45-2041731419841748" ref-type="bibr">45</xref><xref rid="bibr46-2041731419841748" ref-type="bibr"/><xref rid="bibr47-2041731419841748" ref-type="bibr"/>&#x02013;<xref rid="bibr48-2041731419841748" ref-type="bibr">48</xref></sup> Therefore, the cardiac tissue
engineering field needs alternative, less toxic, conditioning protocols that produce
a level of maturity comparable to ES. We present here a novel, alternative chronic
stimulation protocol for cardiac tissue engineering, using expression of light
sensitive ion channels. After extensive review, this is the first successful attempt
at C-OP of engineered ECTs consisting of h-iPSC cardiac cells. Our results show
effective ChIEF transfection of h-iPSC-CM, demonstrate an LED-based optical pacing
protocol for ECTs, and provide evidence of functional ECT maturation in response to
C-OP.</p><p>Our current study does have some limitations that are relevant to highlight. First,
our current study does not include a ChIEF transfected, non-paced subgroup, and thus
it is possible that some of the effects of altered ECT function and gene expression
may be a result of ChIEF transfection rather than C-OP. While this is not likely,
future experiments can address this concern. Second, the focus of our current C-OP
validation study was the impact of C-OP on h-iPSC ECT functional maturation rather
than identifying changes in ion channel expression, function, and molecular
mechanisms for this response. We used classic patch clamping techniques only to
validate optical capture of transfected CM within ECTs and all subsequent functional
data involved optical or electrical field stimulation. Future experiments can
address the electrical properties of individual CM within ECTs or CM isolated from
d14 ECTs using patch clamping techniques, recognizing the significant technical
challenges of this approach, and guide further investigation into changes in ion
channel expression and function. Third, we used visual evidence of beating as
evidence for broad field OP triggered CM depolarization within ECTs rather than
optical dyes. Finally, our current approach is relevant to the scalable maturation
of in vitro ECTs but may be less applicable to in vivo ECT maturation that is more
likely to occur as the result of paracrine signaling and biomechanical loading.
Future experiments can further address excitation dynamics and the ability of narrow
field OP to capture regions within the ECT and assess wave propagation through the
ECT.</p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author contributions:</bold> M.D., W.J.K., F. Ye., F. Yuan, J.P.T., P.C., W.G., and B.B.K. conceived and
designed the experiments; M.D., W.J.K., F. Ye., F. Yuan, J.P.T., S.S., T.N., and
P.C. performed the experiments; M.D., W.J.K., F. Ye., F. Yuan, J.P.T., S.S.,
P.C., W.G., and BBK analyzed the data; H.M. and W.G. contributed
reagents/materials/analysis tools; M.D., W.J.K., F. Ye., T.N., H.M., W.G., and
B.B.K. wrote and revised the manuscript; and B.B.K. provided funding for the
project.</p></fn><fn fn-type="COI-statement"><p><bold>Declaration of conflicting interests:</bold> The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship and/or publication of this article: This work was supported
by the Kosair Charities Pediatric Heart Research Endowment (B.B.K).</p></fn><fn fn-type="other"><p><bold>ORCID iD:</bold> Bradley B Keller <inline-graphic xlink:href="10.1177_2041731419841748-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-5476-6050">https://orcid.org/0000-0001-5476-6050</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-2041731419841748"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanganalmath</surname><given-names>SK</given-names></name><name><surname>Bolli</surname><given-names>R.</given-names></name></person-group>
<article-title>Cell therapy for heart failure: a comprehensive overview of
experimental and clinical studies, current challenges, and future
directions</article-title>. <source>Circ Res</source>
<year>2013</year>; <volume>113</volume>(<issue>6</issue>):
<fpage>810</fpage>&#x02013;<lpage>834</lpage>.<pub-id pub-id-type="pmid">23989721</pub-id></mixed-citation></ref><ref id="bibr2-2041731419841748"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suuronen</surname><given-names>EJ</given-names></name><name><surname>Kuraitis</surname><given-names>D</given-names></name><name><surname>Ruel</surname><given-names>M.</given-names></name></person-group>
<article-title>Improving cell engraftment with tissue
engineering</article-title>. <source>Semin Thorac Cardiovasc Surg</source>
<year>2008</year>; <volume>20</volume>(<issue>2</issue>):
<fpage>110</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">18707642</pub-id></mixed-citation></ref><ref id="bibr3-2041731419841748"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ahadian</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><name><surname>Ramon-Azcon</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>Hybrid hydrogel-aligned carbon nanotube
scaffolds to enhance cardiac differentiation of embryoid
bodies</article-title>. <source>Acta Biomater</source>
<year>2016</year>; <volume>31</volume>:
<fpage>134</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="pmid">26621696</pub-id></mixed-citation></ref><ref id="bibr4-2041731419841748"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bian</surname><given-names>W</given-names></name><name><surname>Jackman Bursac</surname><given-names>N.</given-names></name></person-group>
<article-title>Controlling the structural and functional anisotropy of
engineered cardiac tissues</article-title>. <source>Biofabrication</source>
<year>2014</year>; <volume>6</volume>(<issue>2</issue>):
<fpage>024109</fpage>.<pub-id pub-id-type="pmid">24717534</pub-id></mixed-citation></ref><ref id="bibr5-2041731419841748"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Black</surname><given-names>LD</given-names><suffix>III</suffix></name><name><surname>Meyers</surname><given-names>JD</given-names></name><name><surname>Weinbaum</surname><given-names>JS</given-names></name><etal>et al</etal></person-group>
<article-title>Cell-induced alignment augments twitch force in
fibrin gel-based engineered myocardium via gap junction
modification</article-title>. <source>Tissue Eng Part A</source>
<year>2009</year>; <volume>15</volume>(<issue>10</issue>):
<fpage>3099</fpage>&#x02013;<lpage>3108</lpage>.<pub-id pub-id-type="pmid">19338433</pub-id></mixed-citation></ref><ref id="bibr6-2041731419841748"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>AW</given-names></name><name><surname>Alford</surname><given-names>PW</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Controlling the contractile strength of
engineered cardiac muscle by hierarchal tissue architecture</article-title>.
<source>Biomaterials</source>
<year>2012</year>; <volume>33</volume>(<issue>23</issue>):
<fpage>5732</fpage>&#x02013;<lpage>5741</lpage>.<pub-id pub-id-type="pmid">22594976</pub-id></mixed-citation></ref><ref id="bibr7-2041731419841748"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>KL</given-names></name><name><surname>Clause</surname><given-names>KC</given-names></name><name><surname>Liu</surname><given-names>LJ</given-names></name><etal>et al</etal></person-group>
<article-title>Engineered fetal cardiac graft preserves its
cardiomyocyte proliferation within postinfarcted myocardium and sustains
cardiac function</article-title>. <source>Tissue Eng Part A</source>
<year>2011</year>; <volume>17</volume>(<issue>5&#x02013;6</issue>):
<fpage>585</fpage>&#x02013;<lpage>596</lpage>.<pub-id pub-id-type="pmid">20868205</pub-id></mixed-citation></ref><ref id="bibr8-2041731419841748"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirt</surname><given-names>MN</given-names></name><name><surname>Hansen</surname><given-names>A</given-names></name><name><surname>Eschenhagen</surname><given-names>T.</given-names></name></person-group>
<article-title>Cardiac tissue engineering: state of the art</article-title>.
<source>Circ Res</source>
<year>2014</year>; <volume>114</volume>(<issue>2</issue>):
<fpage>354</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">24436431</pub-id></mixed-citation></ref><ref id="bibr9-2041731419841748"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>M</given-names></name><name><surname>Miyagawa</surname><given-names>S</given-names></name><name><surname>Fukushima</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Enhanced survival of transplanted human induced
pluripotent stem cell-derived cardiomyocytes by the combination of cell
sheets with the pedicled omental flap technique in a porcine
heart</article-title>. <source>Circulation</source>
<year>2013</year>; <volume>128</volume>(<volume>11</volume>
<issue>Suppl. 1</issue>):
<fpage>S87</fpage>&#x02013;<lpage>S94</lpage>.<pub-id pub-id-type="pmid">24030425</pub-id></mixed-citation></ref><ref id="bibr10-2041731419841748"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Masumoto</surname><given-names>H</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Tinney</surname><given-names>JP</given-names></name><etal>et al</etal></person-group>
<article-title>The myocardial regenerative potential of
three-dimensional engineered cardiac tissues composed of multiple human iPS
cell-derived cardiovascular cell lineages</article-title>. <source>Sci
Rep</source>
<year>2016</year>; <volume>6</volume>: <fpage>29933</fpage>.<pub-id pub-id-type="pmid">27435115</pub-id></mixed-citation></ref><ref id="bibr11-2041731419841748"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>T</given-names></name><name><surname>Masumoto</surname><given-names>H</given-names></name><name><surname>Tajima</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Efficient long-term survival of cell grafts
after myocardial infarction with thick viable cardiac tissue entirely from
pluripotent stem cells</article-title>. <source>Sci Rep</source>
<year>2015</year>; <volume>5</volume>: <fpage>16842</fpage>.<pub-id pub-id-type="pmid">26585309</pub-id></mixed-citation></ref><ref id="bibr12-2041731419841748"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Masumoto</surname><given-names>H</given-names></name><name><surname>Tinney</surname><given-names>JP</given-names></name><etal>et al</etal></person-group>
<article-title>Impact of cell composition and geometry on human
induced pluripotent stem cells-derived engineered cardiac
tissue</article-title>. <source>Sci Rep</source>
<year>2017</year>; <volume>7</volume>: <fpage>45641</fpage>.<pub-id pub-id-type="pmid">28368043</pub-id></mixed-citation></ref><ref id="bibr13-2041731419841748"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potapova</surname><given-names>IA</given-names></name><name><surname>Doronin</surname><given-names>SV</given-names></name><name><surname>Kelly</surname><given-names>D</given-names></name><etal>et al</etal></person-group>
<article-title>Enhanced recovery of mechanical function in the
canine heart by seeding an extracellular matrix patch with mesenchymal stem
cells committed to a cardiac lineage</article-title>. <source>Am J Physiol
Heart Circ Physiol</source>
<year>2018</year>; <volume>295</volume>(<issue>6</issue>):
<fpage>H2257</fpage>&#x02013;<lpage>H2263</lpage>.</mixed-citation></ref><ref id="bibr14-2041731419841748"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwan</surname><given-names>J</given-names></name><name><surname>Kwaczala</surname><given-names>AT</given-names></name><name><surname>Ryan</surname><given-names>TJ</given-names></name><etal>et al</etal></person-group>
<article-title>Anisotropic engineered heart tissue made from
laser-cut decellularized myocardium</article-title>. <source>Sci
Rep</source>
<year>2016</year>; <volume>6</volume>: <fpage>32068</fpage>.<pub-id pub-id-type="pmid">27572147</pub-id></mixed-citation></ref><ref id="bibr15-2041731419841748"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>WH</given-names></name><name><surname>Melnychenko</surname><given-names>I</given-names></name><name><surname>Wasmeier</surname><given-names>G</given-names></name><etal>et al</etal></person-group>
<article-title>Engineered heart tissue grafts improve systolic
and diastolic function in infarcted rat hearts</article-title>. <source>Nat
Med</source>
<year>2006</year>; <volume>12</volume>(<issue>4</issue>):
<fpage>452</fpage>&#x02013;<lpage>458</lpage>.<pub-id pub-id-type="pmid">16582915</pub-id></mixed-citation></ref><ref id="bibr16-2041731419841748"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Hua</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Evaluation of changes in morphology and function
of human induced pluripotent stem cell derived cardiomyocytes (HiPSC-CMs)
cultured on an aligned-nanofiber cardiac patch</article-title>. <source>PLoS
ONE</source>
<year>2015</year>; <volume>10</volume>(<issue>5</issue>):
<fpage>e0126338</fpage>.<pub-id pub-id-type="pmid">25993466</pub-id></mixed-citation></ref><ref id="bibr17-2041731419841748"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mannhardt</surname><given-names>I</given-names></name><name><surname>Breckwoldt</surname><given-names>K</given-names></name><name><surname>Letuffe-Breniere</surname><given-names>D</given-names></name><etal>et al</etal></person-group>
<article-title>Human engineered heart tissue: analysis of
contractile force</article-title>. <source>Stem Cell Reports</source>
<year>2016</year>; <volume>7</volume>(<issue>1</issue>):
<fpage>29</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">27211213</pub-id></mixed-citation></ref><ref id="bibr18-2041731419841748"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tobita</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>LJ</given-names></name><name><surname>Janczewski</surname><given-names>AM</given-names></name><etal>et al</etal></person-group>
<article-title>Engineered early embryonic cardiac tissue
retains proliferative and contractile properties of developing embryonic
myocardium</article-title>. <source>Am J Physiol Heart Circ Physiol</source>
<year>2006</year>; <volume>291</volume>(<issue>4</issue>):
<fpage>H1829</fpage>&#x02013;<lpage>H1837</lpage>.<pub-id pub-id-type="pmid">16617136</pub-id></mixed-citation></ref><ref id="bibr19-2041731419841748"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tulloch</surname><given-names>NL</given-names></name><name><surname>Muskheli</surname><given-names>V</given-names></name><name><surname>Razumova</surname><given-names>MV</given-names></name><etal>et al</etal></person-group>
<article-title>Growth of engineered human myocardium with
mechanical loading and vascular coculture</article-title>. <source>Circ
Res</source>
<year>2011</year>; <volume>109</volume>(<issue>1</issue>):
<fpage>47</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">21597009</pub-id></mixed-citation></ref><ref id="bibr20-2041731419841748"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galvez-Monton</surname><given-names>C</given-names></name><name><surname>Bragos</surname><given-names>R</given-names></name><name><surname>Soler-Boti</surname><given-names>JC</given-names></name><etal>et al</etal></person-group>
<article-title>Noninvasive assessment of an engineered
bioactive graft in myocardial infarction: impact on cardiac function and
scar healing</article-title>. <source>Stem Cells Transl Med</source>
<year>2016</year>; <volume>6</volume>(<issue>2</issue>):
<fpage>647</fpage>&#x02013;<lpage>655</lpage>.<pub-id pub-id-type="pmid">28191775</pub-id></mixed-citation></ref><ref id="bibr21-2041731419841748"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Godier-Furnemont</surname><given-names>AF</given-names></name><name><surname>Tiburcy</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>Physiologic force-frequency response in
engineered heart muscle by electromechanical stimulation</article-title>.
<source>Biomaterials</source>
<year>2015</year>; <volume>60</volume>:
<fpage>82</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">25985155</pub-id></mixed-citation></ref><ref id="bibr22-2041731419841748"><label>22</label><mixed-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Jacob</surname><given-names>R</given-names></name><name><surname>Just</surname><given-names>H</given-names></name><name><surname>Holubarsch</surname><given-names>C</given-names></name></person-group> (eds). <source>Cardiac energetics: basic mechanisms and clinical
implications</source>. <publisher-loc>Heidelberg</publisher-loc>;
<publisher-name>Steinkopff-Verlag</publisher-name>, <year>1987</year>, p.
<fpage>25</fpage>.</mixed-citation></ref><ref id="bibr23-2041731419841748"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>JC</given-names></name><name><surname>Taberner</surname><given-names>AJ</given-names></name><name><surname>Tran</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Relating components of pressure-volume area in
Suga&#x02019;s formulation of cardiac energetics to components of the stress-time
integral</article-title>. <source>J Appl Physiol</source>
<year>2012</year>; <volume>113</volume>(<issue>7</issue>):
<fpage>988</fpage>&#x02013;<lpage>995</lpage>.<pub-id pub-id-type="pmid">22837173</pub-id></mixed-citation></ref><ref id="bibr24-2041731419841748"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pinnell</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>S</given-names></name><name><surname>Howell</surname><given-names>S.</given-names></name></person-group>
<article-title>Cardiac muscle physiology</article-title>. <source>BJA
Education</source>
<year>2007</year>; <volume>7</volume>:
<fpage>85</fpage>&#x02013;<lpage>88</lpage>.</mixed-citation></ref><ref id="bibr25-2041731419841748"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maidhof</surname><given-names>R</given-names></name><name><surname>Tandon</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><etal>et al</etal></person-group>
<article-title>Biomimetic perfusion and electrical stimulation
applied in concert improved the assembly of engineered cardiac
tissue</article-title>. <source>J Tissue Eng Regen Med</source>
<year>2012</year>; <volume>6</volume>(<issue>10</issue>):
<fpage>e12</fpage>&#x02013;<lpage>e23</lpage>.<pub-id pub-id-type="pmid">22170772</pub-id></mixed-citation></ref><ref id="bibr26-2041731419841748"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stoppel</surname><given-names>WL</given-names></name><name><surname>Kaplan</surname><given-names>DL</given-names></name><name><surname>Black</surname><given-names>LD</given-names><suffix>3rd</suffix></name></person-group>
<article-title>Electrical and mechanical stimulation of cardiac
cells and tissue constructs</article-title>. <source>Adv Drug Deliv
Rev</source>
<year>2016</year>; <volume>96</volume>:
<fpage>135</fpage>&#x02013;<lpage>155</lpage>.<pub-id pub-id-type="pmid">26232525</pub-id></mixed-citation></ref><ref id="bibr27-2041731419841748"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Au</surname><given-names>HT</given-names></name><name><surname>Cheng</surname><given-names>I</given-names></name><name><surname>Chowdhury</surname><given-names>MF</given-names></name><etal>et al</etal></person-group>
<article-title>Interactive effects of surface topography and
pulsatile electrical field stimulation on orientation and elongation of
fibroblasts and cardiomyocytes</article-title>.
<source>Biomaterials</source>
<year>2007</year>; <volume>28</volume>(<issue>29</issue>):
<fpage>4277</fpage>&#x02013;<lpage>4293</lpage>.<pub-id pub-id-type="pmid">17604100</pub-id></mixed-citation></ref><ref id="bibr28-2041731419841748"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Balint</surname><given-names>R</given-names></name><name><surname>Cassidy</surname><given-names>NJ</given-names></name><name><surname>Cartmell</surname><given-names>SH.</given-names></name></person-group>
<article-title>Electrical stimulation: a novel tool for tissue
engineering</article-title>. <source>Tissue Eng Part B Rev</source>
<year>2013</year>; <volume>19</volume>(<issue>1</issue>):
<fpage>48</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">22873689</pub-id></mixed-citation></ref><ref id="bibr29-2041731419841748"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>D</given-names></name><name><surname>Millard</surname><given-names>R</given-names></name><name><surname>Sivakumaran</surname><given-names>P</given-names></name><etal>et al</etal></person-group>
<article-title>Electrical stimulation promotes cardiac
differentiation of human induced pluripotent stem cells</article-title>.
<source>Stem Cells Int</source>
<year>2016</year>; <volume>2016</volume>:
<fpage>1718041</fpage>.<pub-id pub-id-type="pmid">26788064</pub-id></mixed-citation></ref><ref id="bibr30-2041731419841748"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirt</surname><given-names>MN</given-names></name><name><surname>Boeddinghaus</surname><given-names>J</given-names></name><name><surname>Mitchell</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Functional improvement and maturation of rat and
human engineered heart tissue by chronic electrical
stimulation</article-title>. <source>J Mol Cell Cardiol</source>
<year>2014</year>; <volume>74</volume>: <fpage>151</fpage>&#x02013;<lpage>161</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.05.009</pub-id><pub-id pub-id-type="pmid">24852842</pub-id></mixed-citation></ref><ref id="bibr31-2041731419841748"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lasher</surname><given-names>RA</given-names></name><name><surname>Pahnke</surname><given-names>AQ</given-names></name><name><surname>Johnson</surname><given-names>JM</given-names></name><etal>et al</etal></person-group>
<article-title>Electrical stimulation directs engineered
cardiac tissue to an age-matched native phenotype</article-title>. <source>J
Tissue Eng</source>
<year>2012</year>; <volume>3</volume>(<issue>1</issue>):
<fpage>2041731412455354</fpage>.<pub-id pub-id-type="pmid">22919458</pub-id></mixed-citation></ref><ref id="bibr32-2041731419841748"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McDonough</surname><given-names>PM</given-names></name><name><surname>Glembotski</surname><given-names>CC.</given-names></name></person-group>
<article-title>Induction of atrial natriuretic factor and myosin light chain-2
gene expression in cultured ventricular myocytes by electrical stimulation
of contraction</article-title>. <source>J Biol Chem</source>
<year>1992</year>; <volume>267</volume>(<issue>17</issue>):
<fpage>11665</fpage>&#x02013;<lpage>11668</lpage>.<pub-id pub-id-type="pmid">1376309</pub-id></mixed-citation></ref><ref id="bibr33-2041731419841748"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nunes</surname><given-names>SS</given-names></name><name><surname>Miklas</surname><given-names>JW</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>Biowire: a platform for maturation of human
pluripotent stem cell-derived cardiomyocytes</article-title>. <source>Nat
Methods</source>
<year>2013</year>; <volume>10</volume>(<issue>8</issue>):
<fpage>781</fpage>&#x02013;<lpage>787</lpage>.<pub-id pub-id-type="pmid">23793239</pub-id></mixed-citation></ref><ref id="bibr34-2041731419841748"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Bhalla</surname><given-names>R</given-names></name><name><surname>Saigal</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Effects of electrical stimulation in C2C12
muscle constructs</article-title>. <source>J Tissue Eng Regen Med</source>
<year>2008</year>; <volume>2</volume>(<issue>5</issue>):
<fpage>279</fpage>&#x02013;<lpage>287</lpage>.<pub-id pub-id-type="pmid">18512267</pub-id></mixed-citation></ref><ref id="bibr35-2041731419841748"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pietronave</surname><given-names>S</given-names></name><name><surname>Zamperone</surname><given-names>A</given-names></name><name><surname>Oltolina</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Monophasic and biphasic electrical stimulation
induces a precardiac differentiation in progenitor cells isolated from human
heart</article-title>. <source>Stem Cells Dev</source>
<year>2014</year>; <volume>23</volume>(<issue>8</issue>):
<fpage>888</fpage>&#x02013;<lpage>898</lpage>.<pub-id pub-id-type="pmid">24328510</pub-id></mixed-citation></ref><ref id="bibr36-2041731419841748"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richards</surname><given-names>DJ</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Coyle</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Nanowires and electrical stimulation
synergistically improve functions of hiPSC cardiac
spheroids</article-title>. <source>Nano Lett</source>
<year>2016</year>; <volume>16</volume>(<issue>7</issue>):
<fpage>4670</fpage>&#x02013;<lpage>4678</lpage>.<pub-id pub-id-type="pmid">27328393</pub-id></mixed-citation></ref><ref id="bibr37-2041731419841748"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Serena</surname><given-names>E</given-names></name><name><surname>Figallo</surname><given-names>E</given-names></name><name><surname>Tandon</surname><given-names>N</given-names></name><etal>et al</etal></person-group>
<article-title>Electrical stimulation of human embryonic stem
cells: cardiac differentiation and the generation of reactive oxygen
species</article-title>. <source>Exp Cell Res</source>
<year>2009</year>; <volume>315</volume>(<issue>20</issue>):
<fpage>3611</fpage>&#x02013;<lpage>3619</lpage>.<pub-id pub-id-type="pmid">19720058</pub-id></mixed-citation></ref><ref id="bibr38-2041731419841748"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tandon</surname><given-names>N</given-names></name><name><surname>Marsano</surname><given-names>A</given-names></name><name><surname>Maidhof</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Optimization of electrical stimulation
parameters for cardiac tissue engineering</article-title>. <source>J Tissue
Eng Regen Med</source>
<year>2011</year>; <volume>5</volume>(<issue>6</issue>):
<fpage>e115</fpage>&#x02013;<lpage>e125</lpage>.<pub-id pub-id-type="pmid">21604379</pub-id></mixed-citation></ref><ref id="bibr39-2041731419841748"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Buja</surname><given-names>LM</given-names></name><name><surname>McMillin</surname><given-names>JB.</given-names></name></person-group>
<article-title>Change in expression of heart carnitine palmitoyl transferase I
isoforms with electrical stimulation of cultured rat neonatal cardiac
myocytes</article-title>. <source>J Biol Chem</source>
<year>1996</year>; <volume>271</volume>(<issue>20</issue>):
<fpage>12082</fpage>&#x02013;<lpage>12087</lpage>.<pub-id pub-id-type="pmid">8662650</pub-id></mixed-citation></ref><ref id="bibr40-2041731419841748"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Buja</surname><given-names>LM</given-names></name><name><surname>McMillin</surname><given-names>JB.</given-names></name></person-group>
<article-title>Activation of the cytochrome c gene by electrical stimulation in
neonatal rat cardiac myocytes: role of NRF-1 and c-Jun</article-title>.
<source>J Biol Chem</source>
<year>1998</year>; <volume>273</volume>(<issue>20</issue>):
<fpage>12593</fpage>&#x02013;<lpage>12598</lpage>.<pub-id pub-id-type="pmid">9575220</pub-id></mixed-citation></ref><ref id="bibr41-2041731419841748"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Buja</surname><given-names>LM</given-names></name><name><surname>Scarpulla</surname><given-names>RC</given-names></name><etal>et al</etal></person-group>
<article-title>Electrical stimulation of neonatal
cardiomyocytes results in the sequential activation of nuclear genes
governing mitochondrial proliferation and differentiation</article-title>.
<source>Proc Natl Acad Sci U S A</source>
<year>1997</year>; <volume>94</volume>(<issue>21</issue>):
<fpage>11399</fpage>&#x02013;<lpage>11404</lpage>.<pub-id pub-id-type="pmid">9326621</pub-id></mixed-citation></ref><ref id="bibr42-2041731419841748"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>McMillin</surname><given-names>JB</given-names></name><name><surname>Lewis</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Electrical stimulation of neonatal cardiac
myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenyl
succinate synthetase 1 gene</article-title>. <source>J Biol Chem</source>
<year>2000</year>; <volume>275</volume>(<issue>3</issue>):
<fpage>1855</fpage>&#x02013;<lpage>1863</lpage>.<pub-id pub-id-type="pmid">10636885</pub-id></mixed-citation></ref><ref id="bibr43-2041731419841748"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McDonough</surname><given-names>PM</given-names></name><name><surname>Hanford</surname><given-names>DS</given-names></name><name><surname>Sprenkle</surname><given-names>AB</given-names></name><etal>et al</etal></person-group>
<article-title>Collaborative roles for c-Jun N-terminal kinase,
c-Jun, serum response factor, and Sp1 in calcium-regulated myocardial gene
expression</article-title>. <source>J Biol Chem</source>
<year>1997</year>; <volume>272</volume>(<issue>38</issue>):
<fpage>24046</fpage>&#x02013;<lpage>24053</lpage>.<pub-id pub-id-type="pmid">9295358</pub-id></mixed-citation></ref><ref id="bibr44-2041731419841748"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>To</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Myocardial scaffold-based cardiac tissue
engineering: application of coordinated mechanical and electrical
stimulations</article-title>. <source>Langmuir</source>
<year>2013</year>; <volume>29</volume>(<issue>35</issue>):
<fpage>11109</fpage>&#x02013;<lpage>11117</lpage>.<pub-id pub-id-type="pmid">23923967</pub-id></mixed-citation></ref><ref id="bibr45-2041731419841748"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>JC</given-names></name><name><surname>Entcheva</surname><given-names>E.</given-names></name></person-group>
<article-title>Optogenetic versus electrical stimulation of human
cardiomyocytes: modeling insights</article-title>. <source>Biophys
J</source>
<year>2015</year>; <volume>108</volume>(<issue>8</issue>):
<fpage>1934</fpage>&#x02013;<lpage>1945</lpage>.<pub-id pub-id-type="pmid">25902433</pub-id></mixed-citation></ref><ref id="bibr46-2041731419841748"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bruegmann</surname><given-names>T</given-names></name><name><surname>Malan</surname><given-names>D</given-names></name><name><surname>Hesse</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Optogenetic control of heart muscle in vitro and
in vivo</article-title>. <source>Nat Methods</source>
<year>2010</year>; <volume>7</volume>(<issue>11</issue>):
<fpage>897</fpage>&#x02013;<lpage>900</lpage>.<pub-id pub-id-type="pmid">20881965</pub-id></mixed-citation></ref><ref id="bibr47-2041731419841748"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abilez</surname><given-names>OJ.</given-names></name></person-group>
<article-title>Cardiac optogenetics</article-title>. <source>Conf Proc IEEE Eng
Med Biol Soc</source>
<year>2012</year>; <volume>2012</volume>:
<fpage>1386</fpage>&#x02013;<lpage>1389</lpage>.<pub-id pub-id-type="pmid">23366158</pub-id></mixed-citation></ref><ref id="bibr48-2041731419841748"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deisseroth</surname><given-names>K.</given-names></name></person-group>
<article-title>Optogenetics</article-title>. <source>Nat Methods</source>
<year>2010</year>; <volume>8</volume>(<issue>1</issue>):
<fpage>26</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">21191368</pub-id></mixed-citation></ref><ref id="bibr49-2041731419841748"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abilez</surname><given-names>OJ</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Prakash</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Multiscale computational models for optogenetic
control of cardiac function</article-title>. <source>Biophys J</source>
<year>2011</year>; <volume>101</volume>(<issue>6</issue>):
<fpage>1326</fpage>&#x02013;<lpage>1334</lpage>.<pub-id pub-id-type="pmid">21943413</pub-id></mixed-citation></ref><ref id="bibr50-2041731419841748"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagel</surname><given-names>G</given-names></name><name><surname>Szellas</surname><given-names>T</given-names></name><name><surname>Huhn</surname><given-names>W</given-names></name><etal>et al</etal></person-group>
<article-title>Channelrhodopsin-2, a directly light-gated
cation-selective membrane channel</article-title>. <source>Proc Natl Acad
Sci U S A</source>
<year>2003</year>; <volume>100</volume>(<issue>24</issue>):
<fpage>13940</fpage>&#x02013;<lpage>13945</lpage>.<pub-id pub-id-type="pmid">14615590</pub-id></mixed-citation></ref><ref id="bibr51-2041731419841748"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Valiunas</surname><given-names>V</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><etal>et al</etal></person-group>
<article-title>Stimulating cardiac muscle by light: cardiac
optogenetics by cell delivery</article-title>. <source>Circ Arrhythm
Electrophysiol</source>
<year>2011</year>; <volume>4</volume>(<issue>5</issue>):
<fpage>753</fpage>&#x02013;<lpage>760</lpage>.<pub-id pub-id-type="pmid">21828312</pub-id></mixed-citation></ref><ref id="bibr52-2041731419841748"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>JY.</given-names></name></person-group>
<article-title>A user&#x02019;s guide to channelrhodopsin variants: features,
limitations and future developments</article-title>. <source>Exp
Physiol</source>
<year>2011</year>; <volume>96</volume>(<issue>1</issue>):
<fpage>19</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">20621963</pub-id></mixed-citation></ref><ref id="bibr53-2041731419841748"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakar</surname><given-names>MS</given-names></name><name><surname>Neal</surname><given-names>D</given-names></name><name><surname>Boudou</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Formation and optogenetic control of engineered
3D skeletal muscle bioactuators</article-title>. <source>Lab Chip</source>
<year>2012</year>; <volume>12</volume>(<issue>23</issue>):
<fpage>4976</fpage>&#x02013;<lpage>4985</lpage>.<pub-id pub-id-type="pmid">22976544</pub-id></mixed-citation></ref><ref id="bibr54-2041731419841748"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chan</surname><given-names>V</given-names></name><name><surname>Neal</surname><given-names>DM</given-names></name><name><surname>Uzel</surname><given-names>SG</given-names></name><etal>et al</etal></person-group>
<article-title>Fabrication and characterization of optogenetic,
multi-strip cardiac muscles</article-title>. <source>Lab Chip</source>
<year>2015</year>; <volume>15</volume>(<issue>10</issue>):
<fpage>2258</fpage>&#x02013;<lpage>2268</lpage>.<pub-id pub-id-type="pmid">25857537</pub-id></mixed-citation></ref><ref id="bibr55-2041731419841748"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Klos</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>GF</given-names></name><etal>et al</etal></person-group>
<article-title>Extracellular matrix promotes highly efficient
cardiac differentiation of human pluripotent stem cells: the matrix sandwich
method</article-title>. <source>Circ Res</source>
<year>2012</year>; <volume>111</volume>(<issue>9</issue>):
<fpage>1125</fpage>&#x02013;<lpage>1136</lpage>.<pub-id pub-id-type="pmid">22912385</pub-id></mixed-citation></ref><ref id="bibr56-2041731419841748"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bickford</surname><given-names>ME</given-names></name><name><surname>Zhou</surname><given-names>N</given-names></name><name><surname>Krahe</surname><given-names>TE</given-names></name><etal>et al</etal></person-group>
<article-title>Retinal and tectal &#x0201c;driver-like&#x0201d; inputs converge
in the shell of the mouse dorsal lateral geniculate nucleus</article-title>.
<source>J Neurosci</source>
<year>2015</year>; <volume>35</volume>(<issue>29</issue>):
<fpage>10523</fpage>&#x02013;<lpage>10534</lpage>.<pub-id pub-id-type="pmid">26203147</pub-id></mixed-citation></ref><ref id="bibr57-2041731419841748"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clendenon</surname><given-names>SG</given-names></name><name><surname>Young</surname><given-names>PA</given-names></name><name><surname>Ferkowicz</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Deep tissue fluorescent imaging in scattering
specimens using confocal microscopy</article-title>. <source>Microsc
Microanal</source>
<year>2011</year>; <volume>17</volume>(<issue>4</issue>):
<fpage>614</fpage>&#x02013;<lpage>617</lpage>.<pub-id pub-id-type="pmid">21729357</pub-id></mixed-citation></ref><ref id="bibr58-2041731419841748"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kowalski</surname><given-names>WJ</given-names></name><name><surname>Yuan</surname><given-names>F</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Quantification of cardiomyocyte alignment from
three-dimensional (3D) confocal microscopy of engineered
tissue</article-title>. <source>Microsc Microanal</source>
<year>2017</year>; <volume>23</volume>: <fpage>826</fpage>&#x02013;<lpage>842</lpage>.
doi: <pub-id pub-id-type="doi">10.1017/S1431927617000666</pub-id><pub-id pub-id-type="pmid">28625174</pub-id></mixed-citation></ref><ref id="bibr59-2041731419841748"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chan</surname><given-names>TF</given-names></name><name><surname>Vese</surname><given-names>LA.</given-names></name></person-group>
<article-title>Active contours without edges</article-title>. <source>IEEE Trans
Image Process</source>
<year>2001</year>; <volume>10</volume>(<issue>2</issue>):
<fpage>266</fpage>&#x02013;<lpage>277</lpage>.<pub-id pub-id-type="pmid">18249617</pub-id></mixed-citation></ref><ref id="bibr60-2041731419841748"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sternberg</surname><given-names>SR.</given-names></name></person-group>
<article-title>Biomedical image-processing</article-title>.
<source>Computer</source>
<year>1983</year>; <volume>16</volume>(<issue>1</issue>):
<fpage>22</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="bibr61-2041731419841748"><label>61</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Zuiderveld</surname><given-names>K.</given-names></name></person-group>
<article-title>Contrast limited histogram equalization</article-title>. In:
<person-group person-group-type="editor"><name><surname>Heckbert</surname><given-names>PS</given-names></name></person-group>
<italic>(ed.)</italic>
<source>Graphic gems IV</source>. <publisher-loc>San Diego</publisher-loc>:
<publisher-name>Academic Press</publisher-name>, <year>1994</year>, pp.
<fpage>474</fpage>&#x02013;<lpage>485</lpage>.</mixed-citation></ref><ref id="bibr62-2041731419841748"><label>62</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Mouelhi</surname><given-names>A</given-names></name><name><surname>Sayadi</surname><given-names>M</given-names></name><name><surname>Fnaiech</surname><given-names>F</given-names></name></person-group>
<article-title>Automatic segmentation of clustered breast
cancer cells using watershed and concave vertex graph</article-title>. In:
<source>Proceedings of the 2011 international conference on communications,
computing and control applications (CCCA)</source>, <conf-loc>Hammamet,
Tunisia</conf-loc>, <conf-date>3&#x02013;5 March 2011</conf-date>
<publisher-loc>New York</publisher-loc>:
<publisher-name>IEEE</publisher-name>.</mixed-citation></ref><ref id="bibr63-2041731419841748"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sartiani</surname><given-names>L</given-names></name><name><surname>Bettiol</surname><given-names>E</given-names></name><name><surname>Stillitano</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Developmental changes in cardiomyocytes
differentiated from human embryonic stem cells: a molecular and
electrophysiological approach</article-title>. <source>Stem Cells</source>
<year>2007</year>; <volume>25</volume>(<issue>5</issue>):
<fpage>1136</fpage>&#x02013;<lpage>1144</lpage>.<pub-id pub-id-type="pmid">17255522</pub-id></mixed-citation></ref><ref id="bibr64-2041731419841748"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zsebo</surname><given-names>K</given-names></name><name><surname>Yaroshinsky</surname><given-names>A</given-names></name><name><surname>Rudy</surname><given-names>JJ</given-names></name><etal>et al</etal></person-group>
<article-title>Long-term effects of AAV1/SERCA2A gene transfer
in patients with severe heart failure: analysis of recurrent cardiovascular
events and mortality</article-title>. <source>Circ Res</source>
<year>2014</year>; <volume>114</volume>(<issue>1</issue>):
<fpage>101</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">24065463</pub-id></mixed-citation></ref><ref id="bibr65-2041731419841748"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Czerniecki</surname><given-names>S.</given-names></name></person-group>
<article-title>Use of adeno-associated virus to enrich cardiomyocytes derived
from human stem cells</article-title>. <source>Hum Gene Ther Clin
Dev</source>
<year>2015</year>; <volume>26</volume>(<issue>3</issue>):
<fpage>194</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">26252064</pub-id></mixed-citation></ref><ref id="bibr66-2041731419841748"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sato</surname><given-names>D</given-names></name><name><surname>Shiferaw</surname><given-names>Y</given-names></name><name><surname>Garfinkel</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Spatially discordant alternans in cardiac
tissue: role of calcium cycling</article-title>. <source>Circ Res</source>
<year>2006</year>; <volume>99</volume>(<issue>5</issue>):
<fpage>520</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">16902177</pub-id></mixed-citation></ref><ref id="bibr67-2041731419841748"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>UC</given-names></name><name><surname>Marban</surname><given-names>E</given-names></name><name><surname>Johns</surname><given-names>DC.</given-names></name></person-group>
<article-title>Molecular dissection of cardiac repolarization by in vivo Kv4.3
gene transfer</article-title>. <source>J Clin Invest</source>
<year>2000</year>; <volume>105</volume>(<issue>8</issue>):
<fpage>1077</fpage>&#x02013;<lpage>1084</lpage>.<pub-id pub-id-type="pmid">10772652</pub-id></mixed-citation></ref><ref id="bibr68-2041731419841748"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klimas</surname><given-names>A</given-names></name><name><surname>Ambrosi</surname><given-names>CM</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>OptoDyCE as an automated system for
high-throughput all-optical dynamic cardiac
electrophysiology</article-title>. <source>Nat Commun</source>
<year>2016</year>; <volume>7</volume>: <fpage>11542</fpage>.<pub-id pub-id-type="pmid">27161419</pub-id></mixed-citation></ref></ref-list></back></article>